S.19.02 Preclinical and clinical pharmacology of H3-receptor inverse agonists (Englisch)
- Neue Suche nach: Schwartz, J. C.
- Neue Suche nach: Schwartz, J. C.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
19
;
S203-S204
;
2009
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:S.19.02 Preclinical and clinical pharmacology of H3-receptor inverse agonists
-
Beteiligte:Schwartz, J. C. ( Autor:in )
-
Erschienen in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 19 ; S203-S204
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2009
-
Format / Umfang:S203-S204
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.8 / 615.1
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 19
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophreniaGeffen, Y. / Nudelman, A. / Gil-Ad, I. / Rephaeli, A. / Huang, M. / Savitsky, K. / Klapper, L. / Winkler, I. / Meltzer, H. Y. / Weizman, A. et al. | 2009
- 14
-
Improvement of aggressive behavior and quality of life impairment following S-Adenosyl-Methionine (SAM-e) augmentation in schizophreniaStrous, R. D. / Ritsner, M. S. / Adler, S. / Ratner, Y. / Maayan, R. / Kotler, M. / Lachman, H. / Weizman, A. et al. | 2009
- 23
-
Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonistsLoiseau, F. / Millan, M. J. et al. | 2009
- 34
-
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDDPapakostas, G. I. / Fava, M. et al. | 2009
- 41
-
Antidepressants alleviate the impact of reinforcer downshiftNikiforuk, A. / Popik, P. et al. | 2009
- 49
-
Neurosteroid blood levels in delinquent adolescent boys with conduct disorderGolubchik, P. / Mozes, T. / Maayan, R. / Weizman, A. et al. | 2009
- 53
-
Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosteronede Souza Silva, M. A. / Mattern, C. / Topic, B. / Buddenberg, T. E. / Huston, J. P. et al. | 2009
- 64
-
Interaction between SERTPR and stressful life events on response to antidepressant treatmentMandelli, L. / Marino, E. / Pirovano, A. / Calati, R. / Zanardi, R. / Colombo, C. / Serretti, A. et al. | 2009
- 68
-
The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controlsSchellekens, A. F. / van Oosterwijck, A. W. / Ellenbroek, B. / de Jong, C. A. / Buitelaar, J. K. / Cools, L. / Verkes, R. J. et al. | 2009
- 74
-
Zolpidem-induced amnesia and somnambulism: Rare occurrences?Tsai, J. H. / Yang, P. / Chen, C. C. / Chung, W. / Tang, T. C. / Wang, S. Y. / Liu, J. K. et al. | 2009
- 77
-
Effects of risperidone on glutamate receptor subtypes in developing rat brainChoi, Y. K. / Gardner, M. P. / Tarazi, F. I. et al. | 2009
- 85
-
Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe6-Ang IV in ratsBraszko, J. J. et al. | 2009
- 92
-
Serum creatine kinase activity differentiates alcohol syndromes of dependence, withdrawal and delirium tremensSegal, M. / Avital, A. / Rusakov, A. / Sandbank, S. / Weizman, A. et al. | 2009
- 97
-
Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult miceKarpova, N. N. / Lindholm, J. / Pruunsild, P. / Timmusk, T. n. / Castrén, E. et al. | 2009
- 109
-
Antipsychotic drugs modulate Arc expression in the rat brainFumagalli, F. / Frasca, A. / Racagni, G. / Riva, M. A. et al. | 2009
- 116
-
The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) geneSchilt, T. / Koeter, M. W. / de Win, M. M. / Zinkstok, J. R. / van Amelsvoort, T. r. / Schmand, B. / den Brink, W. v. et al. | 2009
- 125
-
Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortexMaćkowiak, M. / Dudys, D. / Chocyk, A. / Wedzony, K. et al. | 2009
- 138
-
Comparison of the enantiomers of (±)-doxanthrine, a high efficacy full dopamine D1 receptor agonist, and a reversal of enantioselectivity at D1 versus alpha2C adrenergic receptorsPrzybyla, J. A. / Cueva, J. P. / Chemel, B. R. / Hsu, K. J. / Riese, D. J. / McCorvy, J. D. / Chester, J. A. / Nichols, D. E. / Watts, V. J. et al. | 2009
- 147
-
Psychosis and brain volume changes during the first five years of schizophreniaCahn, W. / Rais, M. / Stigter, F. P. / van Haren, N. E. / Caspers, E. / Hulshoff Pol, H. E. / Xu, Z. / Schnack, H. G. / Kahn, R. S. et al. | 2009
- 153
-
Dopamine antagonism inhibits anorectic behavior in an animal model for anorexia nervosaVerhagen, L. A. / Luijendijk, M. C. / Hillebrand, J. J. / Adan, R. A. et al. | 2009
- 161
-
Cerebrolysin lowers kynurenic acid formation — An in vitro studyBaran, H. / Kepplinger, B. et al. | 2009
- 169
-
Objective: remission of depression in primary care:The Oreon StudyAnsseau, M. / Demyttenaere, K. / Heyrman, J. / Migeotte, A. / Leyman, S. / Mignon, A. et al. | 2009
- 177
-
Electrophysiological characterization of the effects of asenapine at 5-HT1A, 5-HT2A, α2-adrenergic and D2 receptors in the rat brainGhanbari, R. / El Mansari, M. / Shahid, M. / Blier, P. et al. | 2009
- 188
-
Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal grayTerzian, A. L. / Aguiar, D. C. / Guimarães, F. S. / Moreira, F. c. et al. | 2009
- 196
-
CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: Role of mGlu5 receptorsTzavara, E. T. / Degroot, A. / Wade, M. R. / Davis, R. J. / Nomikos, G. G. et al. | 2009
- 205
-
Effects of mood stabilizers on brain reward processes in rats: Studies using the intracranial self-stimulation paradigmMavrikaki, M. / Nomikos, G. G. / Panagis, G. et al. | 2009
- 215
-
Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stressBambico, F. R. / Nguyen, N. T. / Gobbi, G. et al. | 2009
- 229
-
Superiority of escitalopram to paroxetine in the treatment of depressionKasper, S. / Baldwin, D. S. / Larsson Lönn, S. / Boulenger, J. P. et al. | 2009
- 238
-
Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brainLeri, F. / Zhou, Y. / Goddard, B. / Levy, A. / Jacklin, D. / Kreek, M. J. et al. | 2009
- 250
-
Optimization of vagus nerve stimulation parameters using the firing activity of serotonin neurons in the rat dorsal rapheManta, S. / Dong, J. / Debonnel, G. / Blier, P. et al. | 2009
- 256
-
Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockadedu Bois, T. M. / Deng, C. / Han, M. / Newell, K. A. / Huang, X. F. et al. | 2009
- 266
-
Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: Convergent data from Tph2 knockout miceGutknecht, L. / Kriegebaum, C. / Waider, J. / Schmitt, A. / Lesch, K. P. et al. | 2009
- 283
-
Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSDMatar, M. A. / Zohar, J. / Kaplan, Z. / Cohen, H. et al. | 2009
- 296
-
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortexKruse, M. S. / Prémont, J. l. / Krebs, M. O. / Jay, T. r. et al. | 2009
- 305
-
Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressantsBroich, K. et al. | 2009
- 309
-
Dopamine and serotonin release in the nucleus accumbens during starvation-induced hyperactivityVerhagen, L. A. / Luijendijk, M. C. / Korte-Bouws, G. A. / Korte, S. M. / Adan, R. A. et al. | 2009
- 317
-
Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesiaZai, C. C. / Tiwari, A. K. / De Luca, V. / Müller, D. J. / Bulgin, N. / Hwang, R. / Zai, G. C. / King, N. / Voineskos, A. N. / Meltzer, H. Y. et al. | 2009
- 329
-
Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampusChen, F. / Madsen, T. M. / Wegener, G. / Nyengaard, J. R. et al. | 2009
- 339
-
Behavioral changes in G72/G30 transgenic miceOtte, D. M. / Bilkei-Gorzó, A. / Filiou, M. D. / Turck, C. W. / Yilmaz, z. / Holst, M. I. / Schilling, K. / Abou-Jamra, R. / Schumacher, J. / Benzel, I. et al. | 2009
- 349
-
Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapyPiccinni, A. / Del Debbio, A. / Medda, P. / Bianchi, C. / Roncaglia, I. / Veltri, A. / Zanello, S. / Massimetti, E. / Origlia, N. / Domenici, L. et al. | 2009
- 356
-
Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cellsPark, S. W. / Lee, J. G. / Ha, E. K. / Choi, S. M. / Cho, H. Y. / Seo, M. K. / Kim, Y. H. et al. | 2009
- 363
-
MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIsHilli, J. / Heikkinen, T. / Rontu, R. / Lehtimäki, T. / Kishida, I. / Aklillu, E. / Bertilsson, L. / Vahlberg, T. / Laine, K. et al. | 2009
- 371
-
The effects of synthetic and endogenous imidazoline binding site ligands on neuronal activity in discrete brain regions of naive and restraint-stressed ratsSmith, K. L. / Roche, M. / Jessop, D. S. / Finn, D. P. et al. | 2009
- 381
-
Research in anxiety disorders: From the bench to the bedsideGarner, M. / Möhler, H. / Stein, D. J. / Mueggler, T. / Baldwin, D. S. et al. | 2009
- 391
-
MDMA reinstates cocaine-seeking behaviour in miceTrigo, J. M. / Orejarena, M. J. / Maldonado, R. / Robledo, P. et al. | 2009
- 398
-
An epigenetic intervention interacts with genetic strain differences to modulate the stress-induced reduction of flurazepam's antiseizure efficacy in the mouseDeutsch, S. I. / Mastropaolo, J. / Burket, J. A. / Rosse, R. B. et al. | 2009
- 402
-
Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortexFumagalli, F. / Caffino, L. / Racagni, G. / Riva, M. A. et al. | 2009
- 409
-
The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depressionVeen, G. / DeRijk, R. H. / Giltay, E. J. / van Vliet, I. M. / van Pelt, J. / Zitman, F. G. et al. | 2009
- 416
-
Effects of the dopamine stabilizer, OSU-6162, on brain stimulation reward and on quinpirole-induced changes in reward and locomotionBenaliouad, F. z. / Kapur, S. / Natesan, S. / Rompré, P. P. et al. | 2009
- 431
-
The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica)Grabiec, M. / Turlejski, K. / Djavadian, R. L. et al. | 2009
- 440
-
D1-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophreniaMcLean, S. L. / Idris, N. F. / Woolley, M. L. / Neill, J. C. et al. | 2009
- 451
-
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depressionMaron, E. / Tammiste, A. / Kallassalu, K. / Eller, T. / Vasar, V. / Nutt, D. J. / Metspalu, A. et al. | 2009
- 457
-
Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiationBlier, P. / Gobbi, G. / Turcotte, J. E. / de Montigny, C. / Boucher, N. / Hébert, C. / Debonnel, G. et al. | 2009
- 466
-
Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: Lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout miceMechanic, J. A. / Sutton, J. E. / Berson, A. E. / Wu, X. / Kwan, J. / Schreiber, R. / Pang, Z. / Button, D. C. et al. | 2009
- 476
-
Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: A comparative double-blind studyAvital, A. / Gross-Isseroff, R. / Stryjer, R. / Hermesh, H. / Weizman, A. / Shiloh, R. et al. | 2009
- 483
-
Increased use of antibiotics in patients treated with clozapineNielsen, J. / Foldager, L. / Meyer, J. M. et al. | 2009
- 487
-
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodentsFattore, L. / Spano, M. S. / Cossu, G. / Scherma, M. / Fratta, W. / Fadda, P. et al. | 2009
- 499
-
DHEA and DHEA-S levels in hospitalized adolescents with first-episode schizophrenia and conduct disorder: A comparison studyStrous, R. D. / Maayan, R. / Kaminsky, M. / Blumensohn, R. / Weizman, A. / Spivak, B. et al. | 2009
- 504
-
Tic hydantoin sigma-1 agonist: Pharmacological characterization on cocaine-induced stimulant and appetitive effectsToussaint, M. / Delair, B. / Foulon, C. / Lempereur, N. g. / Vaccher, C. / Maurice, T. / Melnyk, P. et al. | 2009
- 516
-
Pindolol augmentation enhances response outcomes in first depressive episodesPortella, M. J. / de Diego-Adeliño, J. / Puigdemont, D. / Pérez-Egea, R. / Artigas, F. / Pérez, V. c. et al. | 2009
- 520
-
Advantages and disadvantages of combination treatment with antipsychotics:ECNP Consensus Meeting, March 2008, NiceGoodwin, G. / Fleischhacker, W. / Arango, C. / Baumann, P. / Davidson, M. / de Hert, M. / Falkai, P. / Kapur, S. / Leucht, S. / Licht, R. et al. | 2009
- 533
-
Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: Compound-specific and area-specific distribution within the brainBarna, I. / Till, I. / Haller, J. et al. | 2009
- 542
-
Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) studyNovick, D. / Haro, J. M. / Perrin, E. / Suarez, D. / Texeira, J. o. et al. | 2009
- 551
-
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficitsDavis, J. A. / Gould, T. J. et al. | 2009
- 562
-
Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label studyPae, C. U. / Serretti, A. / Chiesa, A. / Mandelli, L. / Lee, C. / Kim, J. / De Ronchi, D. / Paik, I. H. et al. | 2009
- 571
-
Interactions between the glycine transporter 1(GlyT1) inhibitor SSR504734 and psychoactive drugs in mouse motor behaviourSinger, P. / Feldon, J. / Yee, B. K. et al. | 2009
- 581
-
Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dosePeles, E. / Schreiber, S. / Adelson, M. et al. | 2009
- 589
-
Modulation of sickness behavior by sleep: The role of neurochemical and neuroinflammatory pathways in miceZager, A. / Andersen, M. L. / Lima, M. M. / Reksidler, A. B. / Machado, R. B. / Tufik, S. et al. | 2009
- 603
-
Psychopharmacology for children: From off label use to registrationWohlfarth, T. / Kalverdijk, L. / Rademaker, C. / Schothorst, P. / Minderaa, R. / Gispen-de Wied, C. et al. | 2009
- 609
-
Farewell message from the Founding EditorsMontgomery, S. A. / van Ree, J. M. et al. | 2009
- 610
-
Welcome message from the new editorDavidson, M. et al. | 2009
- 611
-
Molecular tools for assessing human depression by positron emission tomographySmith, D. F. / Jakobsen, S. et al. | 2009
- 629
-
Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concernsVitiello, B. / Correll, C. / van Zwieten-Boot, B. / Zuddas, A. / Parellada, M. / Arango, C. et al. | 2009
- 636
-
Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT)Ishrat, T. / Hoda, M. N. / Khan, M. B. / Yousuf, S. / Ahmad, M. / Khan, M. M. / Ahmad, A. / Islam, F. et al. | 2009
- 648
-
Prenatal viral infection of mice at E16 causes changes in gene expression in hippocampi of the offspringFatemi, S. H. / Folsom, T. D. / Reutiman, T. J. / Huang, H. / Oishi, K. / Mori, S. et al. | 2009
- 654
-
Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatientsShiloh, R. / Schapir, L. / Bar-Ziv, D. / Stryjer, R. / Konas, S. / Louis, R. / Hermesh, H. / Munitz, H. / Weizman, A. / Valevski, A. et al. | 2009
- 659
-
Conditioned place preference induced by social play behavior: Parametrics, extinction, reinstatement and disruption by methylphenidateTrezza, V. / Damsteegt, R. / Vanderschuren, L. J. et al. | 2009
- 670
-
Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6Darvas, M. / Morsch, M. / Racz, I. / Ahmadi, S. / Swandulla, D. / Zimmer, A. et al. | 2009
- 683
-
SSRIs, bone mineral density, and risk of fractures — a reviewSchwan, S. / Hallberg, P. r. et al. | 2009
- 693
-
Intranasal application of dopamine reduces activity and improves attention in Naples High Excitability rats that feature the mesocortical variant of ADHDRuocco, L. A. / de Souza Silva, M. A. / Topic, B. / Mattern, C. / Huston, J. P. / Sadile, A. G. et al. | 2009
- 702
-
Sertindole causes distinct electrocardiographic T-wave morphology changesNielsen, J. / Graff, C. / Hardahl, T. / Andersen, M. P. / Kristoffersen, J. / Struijk, J. J. / Toft, E. / Meyer, J. M. et al. | 2009
- 708
-
Characteristics and consequences of muscarinic receptor activation by tau proteinGómez-Ramos, A. / Díaz-Hernández, M. / Rubio, A. / Díaz-Hernández, J. I. / Miras-Portugal, M. T. / Avila, J. et al. | 2009
- 718
-
Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effectsKato, M. / Okugawa, G. / Wakeno, M. / Takekita, Y. / Nonen, S. / Tetsuo, S. / Nishida, K. / Azuma, J. / Kinoshita, T. / Serretti, A. et al. | 2009
- 726
-
Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitroAmit, B. H. / Gil-Ad, I. / Taler, M. / Bar, M. / Zolokov, A. / Weizman, A. et al. | 2009
- 735
-
The antinociceptive properties of reboxetine in acute painSchreiber, S. / Frishtick, R. / Volis, I. / Rubovitch, V. / Pick, C. G. / Weizman, R. et al. | 2009
- 740
-
Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET studyWilliams, T. M. / Davies, S. J. / Taylor, L. G. / Daglish, M. R. / Hammers, A. / Brooks, D. J. / Nutt, D. J. / Lingford-Hughes, A. et al. | 2009
- 749
-
A novel compound N1,N5-(Z)-N10-(E)-tri-p-coumaroylspermidine isolated from Carthamus tinctorius L. and acting by serotonin transporter inhibitionZhao, G. / Gai, Y. / Chu, W. J. / Qin, G. W. / Guo, L. H. et al. | 2009
- 759
-
A distinct pattern of intracellular glucocorticoid-related responses is associated with extreme behavioral response to stress in an animal model of post-traumatic stress disorderKozlovsky, N. / Matar, M. A. / Kaplan, Z. / Zohar, J. / Cohen, H. et al. | 2009
- 772
-
Frontal EEG predictors of treatment outcome in major depressive disorderIosifescu, D. V. / Greenwald, S. / Devlin, P. / Mischoulon, D. / Denninger, J. W. / Alpert, J. E. / Fava, M. et al. | 2009
- 778
-
Chronic fluoxetine differentially modulates the hippocampal microtubular and serotonergic system in grouped and isolation reared ratsBianchi, M. / Fone, K. C. / Shah, A. J. / Atkins, A. R. / Dawson, L. A. / Heidbreder, C. A. / Hagan, J. J. / Marsden, C. A. et al. | 2009
- 791
-
Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functionsRybakowski, J. K. / Permoda-Osip, A. / Borkowska, A. et al. | 2009
- 796
-
Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depressionLiu, Q. / Li, B. / Zhu, H. Y. / Wang, Y. Q. / Yu, J. / Wu, G. C. et al. | 2009
- 806
-
Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatmentPae, C. U. / Drago, A. / Patkar, A. A. / Jun, T. Y. / Serretti, A. et al. | 2009
- 812
-
Stress-mediated decreases in brain-derived neurotrophic factor as potential confounding factor for acute tryptophan depletion-induced neurochemical effectsvan Donkelaar, E. L. / van den Hove, D. l. / Blokland, A. / Steinbusch, H. W. / Prickaerts, J. et al. | 2009
- 822
-
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian studyfor, t. L. / Dell'Agnello, G. / Maschietto, D. / Bravaccio, C. / Calamoneri, F. / Masi, G. / Curatolo, P. / Besana, D. / Mancini, F. / Rossi, A. et al. | 2009
- 835
-
Brain structural changes associated with chronicity and antipsychotic treatment in schizophreniaThe, N. N. / Tomelleri, L. / Jogia, J. / Perlini, C. / Bellani, M. / Ferro, A. / Rambaldelli, G. / Tansella, M. / Frangou, S. / Brambilla, P. et al. | 2009
- 841
-
BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humansAppel, L. / Geffen, Y. / Heurling, K. / Eriksson, C. / Antoni, G. / Kapur, S. et al. | 2009
- 851
-
Rejuvenation of antioxidant and cholinergic systems contributes to the effect of procyanidins extracted from the lotus seedpod ameliorating memory impairment in cognitively impaired aged ratsXu, J. / Rong, S. / Xie, B. / Sun, Z. / Zhang, L. / Wu, H. / Yao, P. / Zhang, X. / Zhang, Y. / Liu, L. et al. | 2009
- 861
-
Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptorsTanibuchi, Y. / Fujita, Y. / Kohno, M. / Ishima, T. / Takatsu, Y. / Iyo, M. / Hashimoto, K. et al. | 2009
- 868
-
Antidepressive behaviors induced byenriched environment might be modulated by glucocorticoid levelsXu, Z. / Hou, B. / Zhang, Y. / Gao, Y. / Wu, Y. / Zhao, S. / Zhang, C. et al. | 2009
- 876
-
Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident–intruder paradigm in ratsTrent, S. / Drew, C. J. / Mitchell, P. J. / Bailey, S. J. et al. | 2009
- 887
-
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: Interaction studies with citalopramGannon, R. L. / Peglion, J. L. / Millan, M. J. et al. | 2009
- 898
-
Altered expression and modulation of activity-regulated cytoskeletal associated protein (Arc) in serotonin transporter knockout ratsMolteni, R. / Calabrese, F. / Maj, P. F. / Olivier, J. D. / Racagni, G. / Ellenbroek, B. A. / Riva, M. A. et al. | 2009
- 905
-
Antipsychotic effects on auditory sensory gating in schizophrenia patientsSanchez-Morla, E. M. / Santos, J. L. / Aparicio, A. / Garcia-Jimenez, M. A. / Villanueva, C. / Martinez-Vizcaino, V. / Arango, C. et al. | 2009
- I
-
Guide for Authors| 2009
- i
-
Editorial Board| 2009
- S1
-
S.1.01 Brain opioid receptor systems: molecular and functional aspectsKieffer, B. / Gaveriaux-Ruff, C. / Befort, K. / Massotte, D. / Becker, J. et al. | 2009
- S2
-
S.1.02 Engineering receptor subtypes as tools in neuropsychopharmacologyWisden, W. et al. | 2009
- S3
-
P.1.01 An association of the glial cell line-derived neurotrophic factor family receptor alpha-1 gene with schizophreniaAlkelai, A. / Kohn, Y. / Lupoli, S. / Olender, T. / Sarner-Kanyas, K. / Ben-Asher, E. / Lancet, D. / Macciardi, F. / Lerer, B. et al. | 2009
- S5
-
P.1.04 Schizophrenia and cytogenetic aberrations: in search of susceptibility genes and pathwaysBuizer-Voskamp, J. E. / Muntjewerff, J. W. / Vorstman, J. A. / Franke, L. / Hochstenbach, P. F. / Ophoff, R. A. / Kahn, R. S. et al. | 2009
- S6
-
P.1.05 Chronic stress alters cocaine-induced modulation of BDNF expression and signaling in rat brainCaffino, L. / Racagni, G. / Riva, M. A. / Fumagalli, F. et al. | 2009
- S7
-
P.1.06 Limbic dopamine D2-receptor binding and social desirabilityCervenka, S. / Halldin, C. / Farde, L. et al. | 2009
- S9
-
P.1.09 Sarizotan stimulates cell proliferation in neurogenic regions in experimental ParkinsonismEgeland, M. / Zhang, X. / Svenningsson, P. et al. | 2009
- S10
-
P.1.10 Stimulation of 5-HT7 receptors facilitates emotional contextual learningEriksson, T. M. / Youn, J. / Elvander-Tottie, E. / Sjogren, B. / Ekstrom, J. C. / Ogren, S. O. / Svenningsson, P. / Stiedl, O. et al. | 2009
- S11
-
P.1.11 Effects of nicotine on brain function in healthy humans: estimation of inter-individual response heterogeneityEttinger, U. / Williams, S. / Kumari, V. et al. | 2009
- S12
-
P.1.12 Brain-derived neurotrophic factor and dopamine D3 receptor polymorphisms in schizophrenia and therapeutic responseFeher, A. / Juhasz, A. / Rimanoczy, A. / Szekeres, G. / Janka, Z. et al. | 2009
- S13
-
P.1.14 Compared stereoselectivity of the native and recombinant histamine H3 receptor isoformsGbahou, F. / Tardivel-Lacombe, J. / Morisset, S. / Arrang, J. M. et al. | 2009
- S14
-
P.1.15 Transient expression of phospho-acetylated form of histone H3 in medial prefrontal cortex of rats treated with MK-801Guzik, R. / Mackowiak, M. / Dudys, D. / Wedzony, K. et al. | 2009
- S15
-
P.1.16 Serotonin-1A receptor binding potential in dorsal raphe nuclei predicts orbitofrontal reactivity in healthy subjectsHahn, A. / Savli, M. / Stein, P. / Mien, L. K. / Holik, A. / Mitterhauser, M. / Windischberger, C. / Wadsak, W. / Lanzenberger, R. / Kasper, S. et al. | 2009
- S16
-
P.1.17 The study of personality traits variation in gene-gene and gene-environment interactions contextKazantseva, A. / Gaysina, D. / Faskhutdinova, G. / Khusnutdinova, E. et al. | 2009
- S17
-
P.1.18 The brain noradrenergic and serotonergic systems as unknown factors regulating the activity of cytochrome P450Kot, M. / Daniel, W. A. et al. | 2009
- S18
-
P.1.20 Impact of vagus nerve stimulation on monoaminergic neuronsManta, S. / Dong, J. / Debonnel, G. / Blier, P. et al. | 2009
- S19
-
P.1.21 The COMT Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic settingMarino, E. / Benedetti, F. / Colombo, C. / Pirovano, A. / Smeraldi, E. et al. | 2009
- S20
-
P.1.22 Selective modulation of parvalbumin GABAergic interneuron function in-vivo in miceMurray, A. / Black, C. / Cheyne, L. / Riedel, G. / Wisden, W. / Wulff, P. et al. | 2009
- S21
-
P.1.24 Prenatal stress interferes with glutamatergic response to acute swim stress at adulthoodPasini, M. / Fumagalli, F. / Drago, F. / Racagni, G. / Riva, M. A. et al. | 2009
- S22
-
P.1.25 Evaluation of epigenetic effects of psychoactive drugs in primary astrocytesPerisic, T. / Zschocke, J. / Kirmeier, T. / Uhr, M. / Asmus, M. / Rein, T. et al. | 2009
- S23
-
P.1.26 Conditional knockout of mu opioid receptorsPradhan, A. A. / Gardon, O. / Becker, J. / Blad, C. / Filliol, D. / Matifas, A. / Kieffer, B. L. et al. | 2009
- S25
-
P.1.29 The decrease of amygdala hyperactivation in depression is associated with paroxetine serotonin transporter occupancyRuhe, H. G. / Koster, M. / Booij, J. / Veltman, D. J. / Schene, A. H. et al. | 2009
- S26
-
P.1.30 Modulation by spermine of GABAA receptor endogenous phosphorylation and functionSid Ahmed, M. / Kurcewicz, I. / Pumain, R. / Laschet, J. et al. | 2009
- S27
-
P.1.31 Abelson helper integration site 1 and chromosome 6 open reading frame 217 genes in schizophrenia and bipolar disorderSlonimsky, A. / Levi, I. / Agam, G. / Lerer, B. et al. | 2009
- S28
-
P.1.32 Epigenetic effects on BDNF promoter induced by morphine in alcohol preferring (AA) and alcohol non-preferring (ANA) rat modelTiraboschi, E. / Kiianmaa, K. / Castren, E. et al. | 2009
- S31
-
S.2.01 Neurocontrol of feeding behaviour: genes as keys to unravel mechanism underlying behaviourAdan, R. A. et al. | 2009
- S32
-
S.2.02 Neural mechanisms of reinforcement for drug addictionEveritt, B. et al. | 2009
- S35
-
P.2.03 Restraint stress alters tryptophan hydroxylase 2 activity in BALB/c mice: relevance to depressionBrowne, C. A. / Clarke, G. / Dinan, T. G. / Cryan, J. F. et al. | 2009
- S36
-
P.2.04 Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depressionCaggia, F. / Valensisi, C. / Alboni, S. / Benatti, C. / Corsini, D. / Ferrari, F. / Tagliafico, E. / Mendlewicz, J. / Tascedda, F. / Brunello, N. et al. | 2009
- S37
-
P.2.05 Effects of low-dose nicotine on cognitive function and neuronal oxidative stress statusCiobica, A. / Hritcu, L. / Artenie, V. / Padurariu, M. / Bild, W. et al. | 2009
- S39
-
P.2.08 The effects of genetics and early life stress on anxiety-induced activation of the prefrontal cortex in adulthoodGibney, S. / Gosselin, R. D. / Dinan, T. G. / Cryan, J. F. et al. | 2009
- S40
-
P.2.09 The source of resting and physiologically-evoked L-glutamate levels in prefrontal cortex in awake ratsHascup, E. R. / Hascup, K. N. / Pomerleau, F. / Huettl, P. / Gerhardt, G. A. / Kehr, J. et al. | 2009
- S41
-
P.2.10 Neuropeptide Y modulation of the gluta-matergic system in the Flinders Sensitive Line rat: a rat model of depressionHascup, K. N. / Hascup, E. R. / Gerhardt, G. A. / Mathe, A. A. / Kehr, J. et al. | 2009
- S42
-
P.2.11 Smoking cues act as signals of reward or non-reward depending on current deprivation levelKhan, N. S. / Wilson, G. D. / Kumari, V. et al. | 2009
- S43
-
P.2.12 Activation of alpha 7 nicotinic receptors improves phencyclidine-induced deficits in reversal learningMcLean, S. L. / Woolley, M. L. / Neill, J. C. et al. | 2009
- S45
-
P.2.15 Aripiprazole and risperidone improve working memory in healthy volunteers; an fMRI studyMurphy, A. / Deakin, J. F. et al. | 2009
- S46
-
P.2.16 Altered expression of hippocampal mGLUR7 mRNA in a model of depressionOMahony, C. / Dinan, T. G. / Cryan, J. F. et al. | 2009
- S47
-
P.2.17 Repeated tactile deprivation in rat pups disrupts the proposed protective consequences of short maternal separationOreland, S. / Nylander, I. et al. | 2009
- S48
-
P.2.18 Lamotrigine improves anxiety-like behaviour and memory in a rat model of hypoxic-ischaemic encephalopathyPapazisis, G. / Dagklis, T. / Pourzitaki, C. / Melios, G. / Kapoukranidou, D. / Kouvelas, D. et al. | 2009
- S50
-
P.2.21 Mice are resistant to early-life stress-induced alterations in adult behaviourSavignac, H. M. / Dinan, T. G. / Cryan, J. F. et al. | 2009
- S51
-
P.2.22 Lasting effects of chronic social stress in mice: impact of antidepressant treatmentScharf, S. / Sterlemann, V. / Liebl, C. / Ganea, K. / Weber, P. / Putz, B. / Deussing, J. M. / Rein, T. / Mueller, M. B. / Schmidt, M. V. et al. | 2009
- S52
-
P.2.23 5-HT1A receptor desensitization as mechanism underlying the lack of sexual dysfunction in female serotonin transporter knockout ratsSnoeren, E. / Chan, J. S. / Cuppen, E. / Olivier, B. / Oosting, R. S. et al. | 2009
- S53
-
P.2.24 Stress-induced analgesia is mediated by different endogenous opioid systems in C57Bl/6 and DBA/2 miceSolecki, W. / Kubik, J. / Kostrzewa, E. / Przewlocki, R. et al. | 2009
- S54
-
P.2.25 Anxiolytic-like effects of LY487379 an allosteric modulator of mGlu2 receptors in ratsStachowicz, K. / Nikiforuk, A. / Wieronska, J. M. / Chojnacka-Wojcik, E. / Pilc, A. et al. | 2009
- S55
-
P.2.27 Effects of nicotine and ethanol on social play behaviour in adolescent ratsTrezza, V. / Baarendse, P. J. / Vanderschuren, L. J. et al. | 2009
- S56
-
P.2.28 Lack of leptin signalling in the ventral tegmental area accelerates starvation-induced hyperactivityVerhagen, L. A. / Luijendijk, M. C. / de Backer, M. W. / Koppers, M. / Garner, K. M. / DiLeone, R. J. / Adan, R. A. et al. | 2009
- S57
-
P.2.29 Behavioural analysis of mice overexpressing GalR2 under the platelet-derived growth factor-B promoterWardi, T. / Xu, Z. Q. / Hokfelt, T. / Ogren, S. O. et al. | 2009
- S58
-
P.2.31 A pharmacological profile of varenicline: effects on maintenance and relapse to nicotine and alcohol seekingWouda, J. A. / Riga, D. / Stegeman, M. / Schetters, D. / van Mourik, Y. / Schoffelmeer, A. N. / Pattij, T. / de Vries, T. J. et al. | 2009
- S61
-
S.3.01 Gene-environment interactions in neuropsychopharmacologyGorwood, P. / Strat, Y. L. / Dubertret, C. / Ramoz, N. et al. | 2009
- S62
-
P.3.01 Slow frequency oscillations of response-time intra-subject variability in children with ADHDAdamo, N. / Di Martino, A. / Peddis, C. / Reiss, P. / Petkova, E. / Castellanos, F. X. / Zuddas, A. et al. | 2009
- S63
-
P.3.02 Opposite neural effects of the main psychoactive ingredients of cannabis -implications for therapeuticsBhattacharyya, S. / Fusar-Poli, P. / Borgwardt, S. / Martin-Santos, R. / OCarroll, C. / Crippa, J. / Atakan, Z. / McGuire, P. et al. | 2009
- S64
-
P.3.03 A double-blind, placebo-controlled, parallel group study of the effect of Org 25935 on cognitive performanceChristmas, D. / Wilson, S. / Diaper, A. / Rich, A. / Udo do Haes, J. / Sjogren, M. / Nutt, D. et al. | 2009
- S65
-
P.3.04 Antidepressant treatment modulates prefrontal cortex response to threatening cues in subjects at risk for depressionDi Simplicio, M. / Norbury, R. / Harmer, C. J. et al. | 2009
- S67
-
P.3.07 Sleep changes during deep brain stimulation for treatment resistant depression: preliminary findings from a case studyDurant, C. / Wilson, S. / Paterson, L. / Nutt, D. / Gill, S. / Patel, N. / Malizia, A. et al. | 2009
- S68
-
P.3.08 Clinical characteristics and treatment outcome in a representative sample of depressed inpatientsHennings, J. / Owashi, T. / Binder, E. B. / Horstmann, S. / Menke, A. / Kloiber, S. / Uhr, M. / Ising, M. / Holsboer, F. / Lucae, S. et al. | 2009
- S69
-
P.3.09 Association of circadian salivary cortisol and cognitive function in patients with major depressionHinkelmann, K. / Moritz, S. / Riedesel, K. / Botzenhardt, J. / Wiedemann, K. / Kellner, M. / Otte, C. et al. | 2009
- S70
-
P.3.10 Ab Affitopes as active vaccines in the treatment of Alzheimers diasease: preliminary results of two phase I studiesKutzelnigg, A. / Schneeberger, A. / Winkler, D. / Kasper, S. / Mattner, F. / Schmidt, W. et al. | 2009
- S71
-
P.3.12 Are risperidone safety and tolerability in children and adolescents modulated by diagnosis? A retrospective chart reviewPaba, S. / Lecca, L. / Testa, M. / Atzori, P. / Zuddas, A. et al. | 2009
- S72
-
P.3.13 Temperament and character of subjects with treatment increase suicidal ideations in the GENDEP studyPerroud, N. / Uher, R. / Maier, W. / Mors, O. / Henigsberg, N. / Rietschel, M. / Hauser, J. / Farmer, A. E. / Aitchison, K. J. / McGuffin, P. et al. | 2009
- S73
-
P.3.14 Association study of COMT Val108/158Met polymorphism and treatment response to haloperidol, risperidone and clozapinePorcelli, S. / Bosia, M. / Marino, E. / Angelone, S. M. / Smeraldi, E. / Cavallaro, R. et al. | 2009
- S74
-
P.3.15 Serum creatine kinase levels and neuromuscular dysfunction in psychiatric patients: new results of follow-up studyReznik, I. / Volchek, L. / Reznik, M. / Meltzer, H. Y. / Weizman, A. et al. | 2009
- S75
-
P.3.16 Impulsivity in bipolar disorder: a randomized clinical trial of adjunctive oxcarbazepineRosa, A. R. / Cruz, N. / Comes, M. / Vieta, E. et al. | 2009
- S76
-
P.3.17 The effects of modafinil on cognitive and emotional functions in the first episode of psychosisScoriels, L. / Barnett, J. / Murray, G. / Sahakian, B. / Cherukuru, S. / Fielding, M. / Cheng, F. / Jones, P. et al. | 2009
- S79
-
S.4.01 Molecular approaches to future treatmentsKoob, G. F. et al. | 2009
- S80
-
P.4.01 Reversal of cocaine addiction by environmental enrichmentChauvet, C. / Solinas, M. / Thiriet, N. / Rawas, R. E. / Jaber, M. et al. | 2009
- S81
-
P.4.02 Effects of varenicline on dopamine D2/3 receptor binding in rats using ex vivo phosphor storage imagingCrunelle, C. L. / Miller, M. L. / de Bruin, K. / van den Brink, W. / Booij, J. et al. | 2009
- S82
-
P.4.03 High impulsivity predicts relapse to cocaine seeking after extended access: effect of treatment with atomoxetineEconomidou, D. / Pelloux, Y. / Robbins, T. W. / Dalley, J. W. / Everitt, B. J. et al. | 2009
- S84
-
P.4.06 Aripiprazole impact on methamphetamine i.v. self-administration in the olfactory-bulbectomy model of depression in ratsKucerova, J. / Pistovcakova, J. / Vrskova, D. / Nemecek, M. / Sulcova, A. et al. | 2009
- S86
-
P.4.09 NMDA receptors and beta-adrenergic receptors as molecular targets for the prevention of relapse to drug-seekingMilton, A. L. / Everitt, B. J. et al. | 2009
- S87
-
P.4.10 Effects of early exposure to ethanol and/or a cannabinoid receptor agonist on alcohol preference at adult age in miceMolet, J. / Hamon, M. / Lanfumey, L. et al. | 2009
- S88
-
P.4.11 Higher histamine synthesis and release in inbred Roman high versus low avoidance rats: a histaminergic hypothesisMoreno-Delgado, D. / Gimenez-Llort, L. / Fernandez-Teruel, A. / Ortiz, J. et al. | 2009
- S90
-
P.4.14 The opioid receptor-like ORL1 agonist Ro65-6570 reduces the rewarding effects of opioids in the conditioned place preference paradigm in ratsRutten, K. / Vry, J. D. / Bruckmann, W. / Tzschentke, T. M. et al. | 2009
- S91
-
P.4.15 The COMT Val158Met genotype and prefrontal dopamine sensitivity in alcohol dependent patients and healthy controlsSchellekens, A. / Hoppenreijs, S. / Ellenbroek, B. / de Jong, C. / Franke, B. / Buitelaar, J. / Cools, L. / Verkes, R. et al. | 2009
- S92
-
P.4.16 Cannabis use and subclinical psychotic symptoms: is the public mental health at risk?Schubart, C. D. / Boks, M. P. / Sommer, I. E. / Breetvelt, E. J. / Beetz, S. L. / van Gastel, W. / Ophoff, R. A. / Kahn, R. S. et al. | 2009
- S93
-
P.4.17 Interaction between ethanol and the cannabinoid system at GABAergic synapses on basolateral amygdala principal neuronsTalani, G. / Lovinger, D. M. et al. | 2009
- S94
-
P.4.18 Second order schedules of reinforcement to examine the primary and reinforcement-enhancing properties of nicotineWing, V. C. / Shoaib, M. et al. | 2009
- S95
-
P.4.19 Nicotine consumption and cognitive deficits in first episode psychosis; the self medication hypothesisZabala, A. / Segarra, R. / Elizagarate, E. / Ezcurra, J. / Gonzalez Pinto, A. / Eguiluz, J. I. / Ballesteros, J. / Gutierrez, M. et al. | 2009
- S97
-
Author Index| 2009
- S101
-
Keyword Index| 2009
- S103
-
KL.02 The European First Episode Schizophrenia Trial: are all antipsychotics created equal?Kahn, R. et al. | 2009
- S105
-
ME2 Use of dual action antidepressantsKasper, S. et al. | 2009
- S107
-
S.1.01 New molecules for mood disorders; the NewMood EU projectDeakin, J. F. et al. | 2009
- S108
-
S.1.02 Antidepressant pharmacotherapy - 2009 and beyondNutt, D. et al. | 2009
- S110
-
S.1.04 Prediction of suicide in mood disordersRihmer, Z. et al. | 2009
- S111
-
S.2.01 Can PTSD be prevented? Strategic interventions in the `golden hours'Zohar, J. et al. | 2009
- S113
-
S.2.02 The brain prepared to become anxious: predisposing neurobiology in animals and humansHarro, J. / Alttoa, A. / Herm, L. / Kiive, E. / Kurrikoff, T. / Maestu, J. / Mallo, T. / Merenakk, L. / Nordquist, N. / Oreland, L. et al. | 2009
- S115
-
S.2.03 The role of 5-HT1A receptors in emotional memory: implications for anxiety and depressionOgren, S. O. / Eriksson, T. M. / Kehr, J. / Svenningsson, P. / Stiedl, O. et al. | 2009
- S116
-
S.2.04 Are antidepressants really endowed with anxiolytic properties in relevant animal models?Hamon, M. / Mongeau, R. / Martin, C. / Thiebot, M. H. / Lanfumey, L. et al. | 2009
- S117
-
S.2.05 Wolframin (WFS1) deficient mice display increased anxiety and reduced adaptation in a novel environmentVasar, E. / Koks, S. / Luuk, H. / Plaas, M. / Sutt, S. / Raud, S. / Kurrikoff, K. / Abramov, U. / Innos, J. et al. | 2009
- S119
-
S.3.01 Gene-environment interactions in schizophreniaMors, O. / Borglum, A. / Hougaard, D. / Mortensen, P. B. et al. | 2009
- S120
-
S.3.02 Molecular genetics of ADHDLesch, K. P. et al. | 2009
- S121
-
S.3.03 Pharmacogenetic studies in depressionMaron, E. et al. | 2009
- S122
-
S.3.05 Developmental programming of anxiety in miceGross, C. / Lo Iacono, L. / Tsetsenis, T. / Ferreira, T. / Gruart, A. / Delgado-Garcia, J. M. / Fernandez-Guizan, A. et al. | 2009
- S123
-
S.4.01 Neuroplasticity and neuronal cell adhesion moleculesBock, E. / Walmod, P. S. / Secher, T. / Berezin, V. et al. | 2009
- S125
-
S.4.02 Time course in evolution of brain amyloid and its relation to cognitive impairment in Alzheimers diseaseNordberg, A. / Forsberg, A. / Kadir, A. / Almkvist, O. / Engler, H. / Langstrom, B. et al. | 2009
- S126
-
S.4.03 Neural cell adhesion molecule and depression-like phenotype in miceZharkovsky, A. / Aonurm-Helm, A. / Zharkovsky, T. / Beresin, V. / Bock, E. et al. | 2009
- S127
-
S.4.04 Pharmacological induction of neuronal plasticity in the visual cortexCastren, E. et al. | 2009
- S128
-
S.4.05 Novel neurotrophic factors for the treatment of neurodegenerative diseasesSaarma, M. et al. | 2009
- S132
-
P.1.03 Effects of chronic citalopram treatment on the kainic acid induced neurogenesis in adult mouse hippocampusJaako, K. / Zharkovskaja, T. / Zharkovsky, A. et al. | 2009
- S133
-
P.1.04 Depression-like behaviour and reduced levels of the serotonin reuptake transporter in the brain regions of NCAM deficient miceAonurm-Helm, A. / Zharkovsky, A. et al. | 2009
- S135
-
P.1.07 Prodrugs of 3-hydroxy-7-brom-5-phenyl- 1,4-benzdiazepin-2-on for oral deliveryKravchenko, I. / Radaeva, I. et al. | 2009
- S136
-
P.1.08 Mice deficient in ST8SiaII demonstrate working memory impairment: a core feature of schizophrenia-like phenotypeMalinovskaja, K. / Aonurm-Helm, A. / Kalda, A. / Zharkovsky, A. et al. | 2009
- S138
-
P.1.11 Neurochemical effects of prenatal exposure of selective M- and N-cholinoblockers in early ontogenyBairamov, A. A. / Poletaeva, A. O. / Yukina, G. Y. / Meshcherov, S. K. / Proshin, S. N. / Mamina, N. S. / Sapronov, N. S. et al. | 2009
- S139
-
P.1.12 Response to chronic social stress in the rat depends on persistent differences in sucrose consumptionKanarik, M. / Koiv, K. / Matrov, D. / Harro, J. et al. | 2009
- S140
-
P.1.13 Identification of clusters of co-regulated genes that may underlie the phenotypes of high and low exploring ratsAlttoa, A. / Hinsley, T. A. / Koiv, K. / Harro, J. et al. | 2009
- S141
-
P.1.14 Antiaggressive and sedative effect of alpha2-adrenoceptor agonist naphthylmedetomidine in rabbits and monkeysVotava, M. / Hess, L. / Schreiberova, J. / Malek, J. et al. | 2009
- S142
-
P.1.16 Characterisation of ligand binding to melanocortin 4 receptors by fluorescence polarisationVeiksina, S. / Kopanchuk, S. / Rinken, A. et al. | 2009
- S143
-
P.2.01 Duloxetine in the treatment of bulimia nervosa: a case reportCapasso, A. / Siano, C. / Nolfe, G. / Petrella, C. / Milano, L. / Milano, W. et al. | 2009
- S144
-
P.2.02 Citalopram and venlafaxine in the treatment of depressive disorder in elderly patientsGalecki, P. / Florkowski, A. / Jurczyk, A. P. / Bobinska, K. / Pietras, T. / Zboralski, K. et al. | 2009
- S145
-
P.2.04 Trends in treating depression of inpatients with ischaemic heart disease in university hospitalAdomaitiene, V. / Babarskiene, R. / Sepetauskiene, E. / Sajauskiene, S. / Jasaite, G. et al. | 2009
- S147
-
P.2.07 Comparison of the effectiveness of trazodone and venlafaxine therapy in patients with diagnosed depressive disordersZboralski, K. / Florkowski, A. / Talarowska, M. / Wysokinski, A. / Galecki, P. et al. | 2009
- S148
-
P.2.08 Long term follow up of adolescent depression: history of drug prescriptionsPaaren, A. / von Knorring, A. L. / von Knorring, L. et al. | 2009
- S149
-
P.2.09 Serotonin transporter gene promoter polymorphism and family relations: effect on symptoms of depression in adolescentsKurrikoff, T. / Merenakk, L. / Nordquist, N. / Oreland, L. / Harro, J. et al. | 2009
- S151
-
P.3.02 Osteopenia by risperidone-induced hyperprolactinemia: a case reportCapasso, A. / Milano, L. / Petrella, C. / Siano, C. / Milano, W. et al. | 2009
- S152
-
P.3.03 Population study of remission rate in an outpatient psychiatric service in MoscowPotapov, A. / Dedurina, U. / Tsukarzi, E. / Mosolov, S. et al. | 2009
- S153
-
P.3.04 Cognitive functions and level of stress in schizophrenia-like psychoses before treatment and during quetiapine therapyWysokinski, A. / Talarowska, M. / Orzechowska, A. / Gruszczynski, W. / Zboralski, K. et al. | 2009
- S154
-
P.3.06 Composite tardive dystonia associated with antipsychotic drugs for treatment of bipolar affective disorder: a case studyAdomaitiene, V. / Rastenyte, D. / Sveikata, A. / Gumbrevicius, G. / Lauckaite, K. et al. | 2009
- S155
-
P.3.07 Quality of life of family members of patients with first episode psychosis and family-centered treatmentReinson, L. et al. | 2009
- S156
-
P.4.01 Effects of group II metabotropic glutamate receptor antagonist, MGS0039 in rodent tests of anxiety-like behaviourStachowicz, K. / Domin, H. / Pilc, A. et al. | 2009
- S157
-
P.4.02 Influence of drugs with anxiolytic properties on serotonergic receptors in the rat brainKowalczyk, M. / Rump, S. et al. | 2009
- S158
-
P.4.03 Influence of antenatal intermittent normobaric hypoxia in the period of early organogenesis on the behaviour of ratsTrofimova, L. / Graf, A. V. / Dunaeva, T. Y. / Maslova, M. V. / Hirazova, E. E. / Maklakova, A. S. / Sokolova, N. A. et al. | 2009
- S159
-
P.4.04 Interaction between CRF and noradrenergic system in the rat frontal cortexZieba, B. / Domin, H. / Stachowicz, K. / Smialowska, M. et al. | 2009
- S160
-
P.4.06 Trazodone - efficacious way to treat adjustment disordersGalecki, P. / Bobinska, K. / Zboralski, K. / Berent, D. / Florkowski, A. et al. | 2009
- S161
-
P.6.01 Incentive role of amygdaloid CRF receptors in the reinforcing effects of psychoactive drugs in rats: a new conceptShabanov, P. / Lebedev, A. A. et al. | 2009
- S162
-
P.6.02 Substance use and serotonin transporter gene L/S polymorphism in children and adolescentsMerenakk, L. / Maestu, J. / Kurrikoff, T. / Nordquist, N. / Oreland, L. / Harro, J. et al. | 2009
- S163
-
P.7.01 Hyperactive and inattentive symptoms, hostile family environment, and ADRA2A C-1291G polymorphism in healthy adolescentsKiive, E. / Kurrikoff, T. / Maestu, J. / Harro, J. et al. | 2009
- S165
-
P.8.01 Mental retardation - psychopathology, diagnosing and treatment - forty years after Websters theoryBobinska, K. / Galecki, P. / Smigielski, J. / Florkowski, A. / Szemraj, J. et al. | 2009
- S166
-
P.8.02 The hydrolysis of 7-bromo-3-hydroxy-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one esters by pig liver microsomesRomanovskaya, I. I. / Shesterenko, E. A. / Sevastyanov, O. V. / Semenishina, E. A. / Pavlovsky, V. I. / Andronati, S. A. et al. | 2009
- S167
-
P.8.03 Cognitive dysfunctions in a group of patients with fibromyalgia and its consequences for treatmentSamborski, W. / Mojs, E. et al. | 2009
- S173
-
PL.03.01 The schizophrenia paradigm: a hundred-year challengeCarpenter, W. et al. | 2009
- S177
-
S.02.04 Deep brain stimulation in obsessive compulsive disorderDenys, D. / Schuurman, R. et al. | 2009
- S179
-
S.03.04 Inflammation and the glutamate systemMuller, N. / Myint, A. M. / Schwarz, M. J. et al. | 2009
- S180
-
S.04.02 M- and T-tropic HIVs cause apoptosis in rat neuronal cell cultureBiggio, F. / Bachis, A. / Mocchetti, I. et al. | 2009
- S181
-
S.04.05 Effects of early exposure to ethanol and/or a cannabinoid receptor agonist on alcohol preference at adult age in miceMolet, J. / Hamon, M. / Lanfumey, L. et al. | 2009
- S182
-
S.04.08 Serotonin-1A receptor binding potential in dorsal raphe nuclei predicts orbitofrontal reactivity in healthy subjectsHahn, A. / Savli, M. / Stein, P. / Mien, L. K. / Holik, A. / Mitterhauser, M. / Windischberger, C. / Wadsak, W. / Lanzenberger, R. / Kasper, S. et al. | 2009
- S184
-
S.06.01 Diagnostic assessment and multilevel phenotyping in the IMpACT study groupRamos-Quiroga, J. A. / Bosch, R. / Casas, M. et al. | 2009
- S186
-
S.07.01 Quantification of corticosterone and corticotrophin releasing factor in amygdala dialysates: modulation by stressBouchez, G. / Gobert, A. / Rivet, J. M. / Millan, M. J. et al. | 2009
- S188
-
S.07.06 Aripiprazole and risperidone improve working memory in healthy volunteers; an fMRI studyMurphy, A. / McKie, S. / Deakin, J. F. et al. | 2009
- S189
-
S.07.08 Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patientsMiskowiak, K. / Favaron, E. / Hafizi, S. / Inkster, B. / Cowen, P. J. / Goodwin, G. M. / Harmer, C. J. et al. | 2009
- S190
-
S.08.04 Learning about Arc/Arg3.1 and long-term memoriesKuhl, D. / Gross, C. / Mao, X. S. / Ohana, O. et al. | 2009
- S192
-
S.09.05 Modulators of glutamate transmission for the treatment of nicotine and cocaine dependenceMarkou, A. et al. | 2009
- S193
-
S.10.03 Modulating the mineralocorticoid receptor as add-on therapy in antidepressant treatment with SSRI: a randomised controlled trialOtte, C. / Hinkelmann, K. / Moritz, S. / Yassouridis, A. / Jahn, H. / Wiedemann, K. / Kellner, M. et al. | 2009
- S194
-
S.12.02 The glycine transporter 1 and its involvement in memorySinger, P. / Boison, D. / Mohler, H. / Feldon, J. / Yee, B. K. et al. | 2009
- S195
-
S.12.05 Therapeutic use of peroxisome proliferator-activated receptors (PPAR) gamma agonists in the treatment of Alzheimers diseaseLandreth, G. et al. | 2009
- S196
-
S.14.04 Impulse control disorder: prevalence and possible risk factorsWeintraub, D. et al. | 2009
- S198
-
S.15.05 The intriguing interplay between depression and cardiovascular diseaseSkoog, I. et al. | 2009
- S200
-
S.17.01 Neuroimaging of cognitive behavioural therapy for depression and anxiety: towards personalised treatmentSiegle, G. et al. | 2009
- S201
-
S.18.02 HPA stress axis functioning and delinquent behaviour in adolescentsJansen, L. M. / Popma, A. et al. | 2009
- S203
-
S.19.02 Preclinical and clinical pharmacology of H3-receptor inverse agonistsSchwartz, J. C. et al. | 2009
- S204
-
S.20.01 Neuronal plasticity, neurotrophins and antidepressantsCastren, E. et al. | 2009
- S205
-
S.20.04 Consequences of altered BDNF protein levels on hippocampal serotonin neurotransmission and behaviourGardier, A. / Deltheil, T. / Tanaka, K. / Reperant, C. / Hen, R. / David, D. J. / Guiard, B. et al. | 2009
- S206
-
S.21.01 Introduction: recent finding from ongoing NIMH studiesVitiello, B. et al. | 2009
- S207
-
S.21.04 Patient and parent reported outcome: quality of life (QoL) as effective measureCoghill, D. et al. | 2009
- S208
-
S.22.02 Impulsivity and neurocognitive functioning in addictionVerdejo-Garcia, A. et al. | 2009
- S210
-
S.23.03 Gene-environment interactions: relevance to the genetics of depression and anxiety disordersLesch, K. P. et al. | 2009
- S211
-
S.24.03 Amyloid plaque imaging in vivoSeibyl, J. / Marek, K. et al. | 2009
- S212
-
S.26.03 Translational imaging in the development of psychopharmacological drugsBifone, A. et al. | 2009
- S214
-
S.27.03 Decreased VGLUT1 levels and long-term chronic mild stress: animal models addressing specific aspects of major depressionTordera, R. M. / Garcia-Garcia, A. L. / Elizalde, N. / Venzala, E. / Ramirez, M. J. / Del Rio, J. et al. | 2009
- S215
-
S.28.01 Serotonin, fertility and early embryonic developmentCote, F. et al. | 2009
- S216
-
S.28.04 Serotonin transporter gene polymorphism and susceptibility to depressionPezawas, L. et al. | 2009
- S219
-
E.02.03 Efficacy markers in depressionHarmer, C. et al. | 2009
- S220
-
E.03.03 Cognitive behavioural treatment for insomnia: which patients respond?Espie, C. et al. | 2009
- S221
-
E.04.02 The World Federation of Societies of Biological Psychiatry (WFSBP) guidelinesGrunze, H. / Vieta, E. / Goodwin, G. / Bowden, C. / Licht, R. / Moeller, H. J. / Kasper, S. et al. | 2009
- S222
-
E.05.02 Novel insights into the genetics of schizophrenia based on genome-wide association studiesODonovan, M. et al. | 2009
- S225
-
P.1.a.002 Association study of -1727 A/T and -50C/T GSK-3 beta gene polymorphism with suicidal behaviour in depressed patientsYoon, H. K. / Kim, Y. K. / Lee, B. H. / Hwang, J. A. et al. | 2009
- S227
-
P.1.a.005 DRD4 gene polymorphism association and response to methylphenidate in attention deficit hyperactivity disorderLim, M. H. / Lee, K. K. / Paik, K. C. / Kim, H. W. et al. | 2009
- S228
-
P.1.a.007 The role of insulin receptor substrate-1 Gly972Arg polymorphism in the pathogenesis of Alzheimers diseaseJuhasz, A. / Feher, A. / Rimanoczy, A. / Galfi, M. / Kalman, J. / Janka, Z. et al. | 2009
- S230
-
P.1.a.010 The contribution of genetic vulnerability to the multiformity of isotretinoin-induced psychiatric adverse eventsKontaxakis, V. P. / Ferentinos, P. / Havald-Kontaxato, B. / Papadimitriou, G. N. et al. | 2009
- S231
-
P.1.a.012 Interaction effects between serotonin-related gene polymorphisms on emotional intelligenceKang, J. I. / Namkoong, K. / Kim, S. J. et al. | 2009
- S232
-
P.1.a.013 Association study of cannabinoid receptor gene with olanzapine-induced weight gain in schizophreniaKang, S. G. / Choi, J. E. / Park, Y. M. / Lee, H. J. / Lee, S. H. / Kim, L. et al. | 2009
- S233
-
P.1.a.015 Relationship of MAO-A and catechol-O-methyltransferase gene polymorphisms to plasma monoamine metabolites levels in patients and controlsZumarraga, M. / Basterreche, N. / Arrue, A. / Zamalloa, M. I. / Davila, R. / Gonzalez-Torres, M. A. / Guimon, J. et al. | 2009
- S234
-
P.1.a.016 Negative life events and genes of the serotonergic pathway of suicide victims with previous aggressive behaviourPregelj, P. / Tomori, M. Z. / Balazic, J. / Zupanc, T. et al. | 2009
- S235
-
P.1.a.018 Admixture analysis in pharmacogenetics: serotonergic system genes and antipsychotic responseDe Luca, V. / Panariello, F. / de Souza, R. / Muller, D. / Meltzer, H. / Potkin, S. G. / Lieberman, J. / Kennedy, J. L. et al. | 2009
- S236
-
P.1.a.020 Oxytocin receptor polymorphisms and adult attachment style in patients with depressionAbelli, M. / Costa, B. / Pini, S. / Gabelloni, P. / Lari, L. / Cardini, A. / Gesi, C. / Lucacchini, A. / Cassano, G. B. / Martini, C. et al. | 2009
- S238
-
P.1.a.023 Association study between WNT2 polymorphisms and the susceptibility to schizophrenia in Korean populationHwang, D. K. / Kim, H. J. / Yim, S. V. / Choe, B. K. / Park, J. K. / Kim, J. W. / Hong, S. J. / Chung, J. H. et al. | 2009
- S239
-
P.1.a.025 Association study of rs6916861 polymorphism of the FYN gene in bipolar disorder and it subtypesLeszczynska-Rodziewicz, A. / Rajewska-Rager, A. / Szczepankiewicz, A. / Skibinska, M. / Dmitrzak-Weglarz, M. / Hauser, J. et al. | 2009
- S240
-
P.1.b.00l Digital EEG recording during hallucinatory behaviour in a sample of patients with paranoid schizophreniaRabie, M. / Zala, H. / Gaber, A. / Alkhawas, H. et al. | 2009
- S241
-
P.1.b.002 Night-time/daytime and daytime/daytime patterns of melatonin levelsMorera, A. L. / Abreu-Gonzalez, P. / Orozco-Sanmartin, A. / Henry, M. / Guerra-Reyes, A. / Garcia-Hernandez, A. / Fernandez-Lopez, L. / Morales-Garcia, C. R. / Diaz-Mesa, E. / Monzon-Diaz, J. et al. | 2009
- S242
-
P.1.b.004 Ultradian regulations: relationships between sleep EEG power spectra and REM-NREM sleep cyclesNeu, D. / Le Bon, O. / Staner, L. / Linkowski, P. et al. | 2009
- S243
-
P.1.b.005 Significance of fatigue and insomnia complaints in the psychiatric emergency roomNeu, D. / Minner, P. / Le Bon, O. / From, L. / Linkowski, P. / Verbanck, P. et al. | 2009
- S244
-
P.1.b.007 Developmental expression and activity of carboxylesterase 1 and carboxylesterase 2 in mouse and humanZhu, H. J. / Appel, D. I. / Donovan, J. L. / DeVane, C. L. / Markowitz, J. S. et al. | 2009
- S245
-
P.1.b.009 Effects of Chlorpromazine on GIRK channel expressed transiently in HEK cellsKim, E. / Kim, K. / Hyun, S. et al. | 2009
- S246
-
P.1.b.011 Histamine H3 receptor activation decreases gamma oscillation power and causes desynchronization of action potentialsAndersson, R. / Fisahn, A. / Lindskog, M. et al. | 2009
- S247
-
P.1.b.013 Chronic sleep deprivation and pain perceptionSahin, L. / Ascioglu, M. / Taskin, E. / Arris, A. S. et al. | 2009
- S248
-
P.1.b.015 Chronic social stress decreases cerebral oxidative metabolism in rats with persistently high sucrose consumptionKanarik, M. / Matrov, D. / Koiv, K. / Harro, J. et al. | 2009
- S249
-
P.1.b.016 The influence of repeated administration of the selective mGluR7 allosteric agonist AMN082 on GABA synthesis and GABA-B receptor expression in miceWieronska, J. M. / Branski, P. / Nowak, G. / Pile, A. et al. | 2009
- S250
-
P.1.b.018 Functional reorganization of dorso-medial medullar local neural networks and ECG alteration under pain influencePrudnikau, H. et al. | 2009
- S252
-
P.1.c.003 Opiates and SSRIs: risk for serotonin syndromeTimmerman, L. / Hoek-Mensink, A. V. et al. | 2009
- S254
-
P.1.c.006 Targeted delivery of PEGylated liposomes to gap junction protein Connexin-43 (Cx43) positive C6 glioma cellsBaklaushev, V. P. / Gurina, O. I. / Grinenko, N. F. / Jhyrkov, Y. U. / Chekhonin, V. P. et al. | 2009
- S255
-
P.1.c.008 D-serine adjuvant treatment alleviates motor and behavioural symptoms in idiopathic Parkinsons diseaseHeresco-Levy, U. / Javitt, D. C. / Gelfin, Y. / Kaufman, Y. / Levin, R. / Korn-Lubetzki, I. / Bloch, B. / Wolosker, H. / Kremer, I. et al. | 2009
- S257
-
P.1.c.011 The changes in cortical BDNF level upon chronic administration of venlafaxine, olanzapine and nicotineNowakowska, E. / Czubak, A. / Kus, K. / Burda, K. et al. | 2009
- S258
-
P.1.c.013 Differences of brain activation by visual erotic stimuli between patients treated with SSRI and mirtazapineKim, W. / Chae, J. H. et al. | 2009
- S259
-
P.1.c.015 Fentanyl and SNC-80 upregulate p25, an activator of cdk5, in rat brain: functional interaction with the MEK-ERK pathwayRamos-Miguel, A. / Garcia-Sevilla, J. A. et al. | 2009
- S260
-
P.1.c.016 Neuropharmacological activity of new l-valine peptidomimetics - in vitro and in vivo studiesEncheva, E. / Tancheva, L. / Novoselski, M. / Petkov, V. / Chakalarova, J. / Gorneva, G. / Tsekova, D. / Gurt, I. / Katz, E. et al. | 2009
- S261
-
P.1.c.018 Different neurochemical effects of R and S enantiomers of tetrahydroisoquinoline on dopamine metabolism in rat brainAntkiewicz-Michaluk, L. / Romanska, I. / Boksa, J. / Bojarski, A. / Michaluk, J. et al. | 2009
- S263
-
P.1.c.021 The effect of pharmacological manipulation of endocannabinoid tone in the ventral hippocampus on expression of fear-conditioned analgesia in ratsFord, G. K. / Dolan, K. / Finn, D. P. et al. | 2009
- S264
-
P.1.c.023 GABA-A receptor-mediated neurotransmission in ventromedial hypothalamus modulates fear and antinociceptionFreitas, R. L. / Castiblanco-Urbina, M. A. / Uribe-Marino, A. / Elias-Filho, D. H. / Coimbra, N. C. et al. | 2009
- S266
-
P.1.c.026 Opioid and nonopioid stress-induced analgesia are mediated by spinal 5-HT7 receptorsDogrul, A. / Seyrek, M. / Deveci, M. S. / Kahraman, S. et al. | 2009
- S267
-
P.1.c.028 Systemically and spinally administered etanercept, a TNF-alpha antagonist, blocks allodynia in diabetic miceDogrul, A. / Gul, H. / Yesilyurt, O. / Ulas, U. H. / Yildiz, O. et al. | 2009
- S268
-
P.1.c.030 Effect of dopamine and nitric oxide systems manipulation on spontaneous prepulse inhibition disruption in Wistar ratsPereira, A. I. / Lazzarini, M. / Del Bel, E. A. et al. | 2009
- S269
-
P.1.c.031 Tolerance effect to pregabalin in a subpopulation of fibromyalgiaKosma, K. / Kontoangelos, K. / Roumbou, K. / Papadopoulos, G. / Anastasiou, M. et al. | 2009
- S270
-
P.1.c.033 Effects of carnosine on long-term plasticity of perforant pathway/dentate gyrus synapses in rats: an in vivo modelDolu, N. / Suer, C. / Artis, S. / Aydogan, S. et al. | 2009
- S271
-
P.1.c.035 Celecoxib, a cyclooxygenase-2 inhibitor enhances pentylenetetrazole induced seizure threshold in miceMesdaghinia, A. / Heydari, A. / Khazaee, P. et al. | 2009
- S272
-
P.1.c.037 Efficacy of intramuscular aripiprazole in the management of agitated patientsDe Filippis, S. / Cuomo, I. / De Persis, S. / Parisi, M. / Di Pasquale, C. / De Vecchis, L. / Penna, L. / Sciarretta, A. et al. | 2009
- S274
-
P.l.c.040 Neuroprotective effect of timing for vinpocetine treatment on cerebral ischemia/reperfused ratsKayacilar, C. / Tekin, D. / Zengin, A. / Nurten, A. / Kara, I. et al. | 2009
- S275
-
P.l.c.042 Antihyperalgesic and antiallodynic effect of chronic lactoferrin administration in neuropathic painOnal, A. / Kayalioglu, G. / Parlar, A. / Keser, A. / Ulker, S. et al. | 2009
- S276
-
P.l.c.044 Paradoxical effects of GABA on the in vivo uptake of the partial inverse GABA agonist [3H]Ro15-4513 in rat brainTyacke, R. J. / Robinson, E. S. / Harris, A. / Lingford-Hughes, A. R. / Nutt, D. J. et al. | 2009
- S277
-
P.l.c.045 Effects of catechin and epicatechin on rat phrenic nerve-hemidiaphragm preparationZengin, A. / Nurten, A. et al. | 2009
- S278
-
P.1.c.047 Hippocampal nociceptin receptors and memory: possible implications for anti-alcohol effects of nociceptin ligandsJohansson, B. / Kuzmin, A. / Madjid, N. / Terenius, L. / Ogren, S. O. et al. | 2009
- S279
-
P.1.c.049 Relation of proepileptic activity of indomethacin with adrenal gland hormonesSuleyman, H. / Hacimuftuoglu, A. / Cadirci, E. / Albayrak, A. / Polat, B. / Alp, H. H. / Halici, Z. et al. | 2009
- S280
-
P.1.c.0511 Heterodimerization of mu opioid receptor and nociceptin/orphanin FQ peptide receptor alters g protein couplingGunduz, O. / Baldini, E. / Borsodi, A. / Benyhe, S. / Corbani, M. et al. | 2009
- S282
-
P.l.c.054 Opioid receptors of dorsomedial and ventrolateral periaqueductal grey matter modulate the post-ictal antinociceptionFreitas, R. L. / Bolognesi, L. I. / Twardowschy, A. / Correa, F. M. / Sibson, N. R. / Coimbra, N. C. et al. | 2009
- S283
-
P.l.c.056 The most frequent used drugs at psychiatric clinical centre Kragujevac in 2007Mihajlovic, G. / Djukic Dejanovic, S. / Radmanovic, B. / Borovcanin, M. et al. | 2009
- S284
-
P.l.c.058 Evaluation of an inpatient therapeutic interchange protocol for second generation antidepressants and clinical follow-upMartinez-Granados, F. / Climent-Grana, E. / Perez-Martinez, E. / Ordovas-Baines, J. P. et al. | 2009
- S285
-
P.1.c.060 Effect of agmatine on pentilentetrazole-induced kindling in ratsAricioglu, F. / Agalar, Z. / Kaya, M. / Gurses, C. et al. | 2009
- S286
-
P.l.c.062 Prenatal exposure of selective cholinoblockers disturbs brain neurotransmitter systems and sexual function in ratsBairamov, A. A. / Yukrna, G. Y. / Mamina, N. S. / Shabanov, P. D. et al. | 2009
- S287
-
P.1.d.00l Effects of JNJ16259685, an antagonist of glutamate mGlul receptors, on anxiety tested in the elevated plus maze in miceDe Castro, V. / Martin-Lopez, M. / Navarro, J. F. et al. | 2009
- S288
-
P.1.d.003 Experimental researches on the modulatory effects of some dopaminergic agents in visceral nociceptionTartau, L. / Lupusoru, R. V. / Ghiciuc, C. M. et al. | 2009
- S289
-
P.1.d.005 Cannabidiol-mediated modulation of the defensive behaviour evoked by GABA(A) receptor blockade in the inferior colliculusTwardowschy, A. / Crippa, J. A. / Hallak, J. E. / Coimbra, N. C. et al. | 2009
- S291
-
P.1.d.008 The effects of fluoxetine on behaviours in an animal model of transient forebrain ischemic in gerbilsSon, B. / Li, H. / Kim, D. / Won, M. / Yan, J. et al. | 2009
- S292
-
P.1.d.010 Peak in the theta power spectrum of EEG shows strong association with voluntary movements in ratsKatai, Z. / Kitka, T. / Garay, T. / Molnar, E. / Bagdy, G. et al. | 2009
- S294
-
P.1.d.013 Prenatal stress increases an anxiety, and alters corticosterone response to 5-HT2A/C agonist in adult female offspringOrdyan, N. / Pivina, S. / Shamolina, T. / Fedotova, J. et al. | 2009
- S295
-
P.1.d.015 Behavioural and molecular correlations in the rat chronic mild stress model of depressionWiborg, O. / Henningsen, K. / Bouzinova, E. / Christensen, T. / Christiansen, S. et al. | 2009
- S296
-
P.1.d.017 Blockade of 5-alpha reductase reduces compulsive behaviors in miceBini, V. / Frau, R. / Collu, M. / Paba, S. / Devoto, P. / Marrosu, F. / Bortolato, M. et al. | 2009
- S297
-
P.1.d.019 The effects of atrial natriuretic peptide on the emotional activity in rats exposed to chronic immobilization stressYildirim, E. A. / Mengi, M. / Turhan, S. / Yurdakos, E. et al. | 2009
- S298
-
P.1.d.020 Object recognition and location memory in rats with electrolytic lesions of the dorsal and ventral striatal regionsMaglakelidze, G. / Burjanadze, M. / Naneishvili, T. et al. | 2009
- S299
-
P.1.d.022 Lipoxin A4 exerts neuroprotective effects mediated by the endocannabinoid system in miceTakahashi, R. N. / Pamplona, F. A. et al. | 2009
- S300
-
P.1.e.002 Changes in brain perfusion in drug-naive panic patients with SPECT following cognitive-behavioural therapyKim, J. B. / Nam, W. H. / Chae, J. H. / Chang, E. J. / Ryu, S. Y. / Won, K. S. / Zeon, S. K. / Chung, Y. A. / Sung, H. M. et al. | 2009
- S301
-
P.1.e.003 Disorder-specific right inferior prefrontal dysfunction during inhibition in boys with ADHD compared to boys with OCDRubia, K. / Cubillo, A. / Smith, A. / Woolley, J. / Brammer, M. et al. | 2009
- S302
-
P.1.e.005 Reduced activation and functional interconnectivity within fronto-striatal systems in adults with childhood ADHDCubillo, A. / Halari, R. / Taylor, E. / Rubia, K. et al. | 2009
- S303
-
P.1.e.007 Fronto-cerebellar brain dysfunction in adults with childhood ADHD during sustained attention and rewardCubillo, A. / Halari, R. / Smith, A. B. / Taylor, E. / Rubia, K. et al. | 2009
- S304
-
P.1.e.008 Methylphenidate modulates inferior and orbitofrontal brain activation in ADHD during sustained attention and rewardRubia, K. / Halari, R. / Cubillo, A. I. / Taylor, E. T. et al. | 2009
- S305
-
P.1.e.010 Understanding postpartum blues: a time course of MAO-A levels in the living human brain during the postpartum periodSacher, J. / Wilson, A. A. / Rusjan, P. / Hassan, S. / Jacobs, L. / Bloomfield, P. M. / Stewart, D. E. / Houle, S. / Meyer, J. H. et al. | 2009
- S307
-
P.1.e.013 Lorazepam impairs processing of frequency changes andnovel sounds: combined MEG/EEG studyKahkonen, S. / Pekkonen, E. / Horn, P. / Huttunen, J. / Kivisaari, R. / Korostenskaja, M. et al. | 2009
- S308
-
P.1.e.015 Involvement of the endocannabinoid system in associative memory: a pharmacological MRI studyBossong, M. G. / Van Hell, H. H. / Jager, G. / Brouwer, A. / Kahn, R. S. / Ramsey, N. F. et al. | 2009
- S309
-
P.1.e.017 Chronic SSRI treatment induces adaptive changes in brain 5-HT phMRI responsesDowney, D. / Davies, K. E. / McKie, S. / Juhasz, G. / Anderson, I. M. / Smith, M. A. / Deakin, J. F. / Williams, S. R. et al. | 2009
- S310
-
P.1.e.018 Neural substrates of major depressive disorder: A voxel-based morphometric imaging studyHam, B. J. / Lee, M. S. / Joe, S. H. / Jung, I. K. et al. | 2009
- S311
-
P.1.e.020 Brain metabolite alterations in subjects at ultra-high risk for psychosis: magnetic resonance spectroscopy studyByun, M. / Choi, J. / Yoo, S. / Kang, D. / Choi, C. / Jang, D. / Jung, W. / Lee, J. / Kwon, J. et al. | 2009
- S313
-
P.1.e.023 Longitudinal assessment of presynaptic dopamine function in the striatum: a [18]F-DOPA PET test-retest studyEgerton, A. / Demjaha, A. / Grasby, P. M. / McGuire, P. K. / Murray, R. M. / Howes, O. D. et al. | 2009
- S314
-
P.1.e.025 Effects of the Amazonian psychoactive plant beverage ayahuasca on prefrontal and limbic regions during a language task: a fMRI studyAlmeida Prado, D. / Pinto, J. / Crippa, J. / Santos, A. / Ribeiro, S. / Araujo, D. / Zuardi, A. / Chaves, C. / Hallak, J. et al. | 2009
- S315
-
P.1.e.027 Psychotic symptoms and relation to periventricular brain lesions in patients with multiple sclerosisKostaras, P. / Moussas, G. / Tselebis, A. / Karra, F. / Maltezou, M. et al. | 2009
- S317
-
P.1.e.030 Structural and metabolic abnormalities in bipolar I vs II disorder from combined voxel-based morphometry MRI and (18)F-fluorodeoxyglucose PET brain imagingSu, T. / Cheng-Ta Li, C. T. / Li-Fen Chen, L. F. / Yong-Shen Chen, Y. S. / Shyh-Jen Wang, S. J. / Jen-Chuen Hsieh, J. C. et al. | 2009
- S318
-
P.1.e.032 Gray matter volume reduction in right middle temporal gyrus and orbitofrontal cortex in panic disorder - a voxel-based morphometry MRI studySobanski, T. / Wagner, G. / Peikert, G. / Gruhn, U. / Schlosser, R. G. / Sauer, H. et al. | 2009
- S319
-
P.1.f.00l Prenatal exposure to alcohol changes the development of brain vessels in human embryos and fetusesSolonsky, A. V. / Logvinov, S. V. / Semke, V. Y. et al. | 2009
- S322
-
P.1.g.004 Developing assessment tool of competency to consent to psychiatric admission treatment in the mentally illKim, S. / Yi, J. / Jeon, Y. / Rhee, M. / Seo, M. / Cho, S. et al. | 2009
- S323
-
P.1.g.006 TMS over the dorsal visual pathway generates schizophrenia-like visual-deficit in healthy controlsAmiaz, R. / Gershon, A. / Vainiger, D. / Weiser, M. / Lavidor, M. / Javitt, D. C. et al. | 2009
- S324
-
P.1.g.007 Preliminary analysis of the functional consequences of the CACNA1C gene polymorphism in Bipolar DisorderFrangou, S. / Ruberto, G. / Vassos, E. et al. | 2009
- S325
-
P.1.g.009 Psychomotor performance, fatigue, sleepiness and cognitive function in in-patients with major depressionNeu, D. / Montana, X. / Vandriette, Y. M. / Kornreich, C. / Peigneux, P. / Verbanck, P. / Linkowski, P. / Le Bon, O. et al. | 2009
- S326
-
P.1.g.011 Chronic rapid eye movement sleep deprivation deteriorates long-term potentiation in the rat hippocampusArtis, A. S. / Suer, C. / Dolu, N. / Sahin, L. / Ascioglu, M. et al. | 2009
- S327
-
P.1.g.014 Effectiveness of cognitive behavioral therapy for comorbid obsessive compulsive disorder in patients with psychosisTundo, A. / Salvati, L. / Di Spigno, D. / Parena, A. / Cieri, L. / Sciortino, S. et al. | 2009
- S328
-
P.1.g.015 Specific cognitive profile in depression remitters following electroconvulsive therapy: a comparison to nonremittersSemkovska, M. / McLoughlin, D. M. et al. | 2009
- S329
-
P.1.g.017 Sodium fluoride induced memory impairment is associated with changes in striatal monoaminergic levelsLosso, E. M. / Pereira, M. / Dombrowski, P. A. / Da Cunha, C. / Andreatini, R. et al. | 2009
- S331
-
P.1.h.002 Cognitive functioning in childhood and adulthood risk for depressive symptoms in the 1970 British birth cohortMatei, V. / Reichenberg, A. et al. | 2009
- S332
-
P.1.h.004 Socio-demographic and clinical characteristics of elderly patients in acute psychiatric unit during ten year follow upVazquez, M. S. / Carton, M. M. / Carton, M. C. / Perez, E. B. et al. | 2009
- S333
-
P.1.h.006 Frequency of insomnia symptoms and their `day-after' consequences in Mexican patients treated by primary care physiciansEspinosa-Avila, J. / Group, G. E. et al. | 2009
- S334
-
P.1.h.008 Prevalence of chronic obstructive pulmonary disease among those with serious mental illnessKarkanias, A. / Kapsokaliva, A. / Moussas, G. / Lerikou, M. / Stournara, L. / Pavlakou, G. / Anagnostopoulou, O. et al. | 2009
- S336
-
P.1.i.001 A year in the psychiatric clinic of general hospital Thriasio; statistical analysis of the patients characteristicsNeroutsos, E. / Vagionis, G. / Andreou, G. / Fiste, M. et al. | 2009
- S337
-
P.1.i.003 Chain reactions: polyunsaturated fatty acids and the depressive phenotype in maternally separated rodentsClarke, G. / OMahony, S. M. / Ross, P. / Stanton, C. / Cryan, J. F. / Dinan, T. G. et al. | 2009
- S338
-
P.1.i.005 Influence of psychotropic medication on sexual experiences of patients suffering from schizophrenia or depressionPeitl, M. V. / Peitl, V. / Pavlovic, E. / Ljubicic, D. et al. | 2009
- S339
-
P.1.i.007 The effects of providing verbal and translated psychiatric medication information to non-English speaking (CALD) patients with a mental illnessTran, N. / Castle, D. et al. | 2009
- S340
-
P.1.i.008 Identifying patients with high pharmacy consumption by using the adjusted clinical groups in a primary care settingSicras-Mainar, A. / Navarro-Artieda, R. / Velasco-Velasco, S. / Serrat-Tarres, J. / Prados, A. / Estelrich, J. et al. | 2009
- S341
-
P.1.i.010 Social and cognitive functioning as risk factors for suicide: a historical-prospective cohort studyWerbeloff, N. / Weiser, M. / Lubin, G. et al. | 2009
- S342
-
P.1.i.012 Treatment of insomnia in patients with schizophreniaDimova, O. / Filovska, V. F. / Kujundziska, K. M. et al. | 2009
- S343
-
P.1.i.014 Serum levels of vitamin B12, folate, and homocysteine in patients with persistent suicidal ideation or suicide attemptTrujillo, F. J. / Raya, J. M. / Monzon, J. / Rodriguez-Martos, T. / Renshaw, A. / Morabito, L. / Henry, M. / Morales, R. M. / Jimenez-Sosa, A. / Gracia, R. et al. | 2009
- S344
-
P.1.i.015 Serum folate, vitamin B12, and homocysteine in acute patients with schizophrenia, depression, or bipolar disorderTrujillo, F. J. / Raya, J. M. / Monzon, J. / Rodriguez-Martos, T. / Salinas, M. / Martin-Santos, T. / Sangines, M. / Henry, M. / Jimenez-Sosa, A. / Gracia, R. et al. | 2009
- S345
-
P.1.i.017 Amelioration of affective disorders and quality of life in obstructive sleep apnea (OSA) patients following continuous positive airway pressure (CRAP) therapyPaparrigopoulos, T. J. / Economou, N. T. / Koutsourelakis, I. / Giannakopoulou, H. / Kritikou, I. / Perraki, E. / Christidi, F. / Zalonis, I. / Vagiakis, E. / Soldatos, C. R. et al. | 2009
- S346
-
P.1.i.018 Clinical semantics, semiology and auto-evaluation. The challenging case of fatigue and sleepinessNeu, D. / Pieters, D. / Morel, E. / Montana, X. / Hoffmann, G. / Verbanck, P. / Cluydts, R. / Linkowski, P. / Bon, O. L. et al. | 2009
- S347
-
P.1.i.020 Psychopathology during pregnancy and postpartum: characterization of a selected high risk Italian samplePetrilli, G. / Anniverno, R. / Mencacci, C. / Blom, J. M. et al. | 2009
- S348
-
P.1.i.022 High level of TV viewing is associated with silent inflammationKorkeila, J. / Markkula, J. / Korhonen, P. et al. | 2009
- S349
-
P.1.i.024 Arnold-Chiari type I malformation with psychiatric symptoms: a case reportOrhan, F. O. / Yuksel, Z. / Altunoren, O. / Altun, I. / Berk, S. / Akman, O. / Karaaslan, M. F. et al. | 2009
- S350
-
P.1.i.026 The relationships between second to fourth digit length ratio (2D:4D) and psychological characteristicsKang, D. / Kim, H. / Lee, W. / Lee, Y. et al. | 2009
- S351
-
P.1.i.029 Pharmacist interventions involving psychotropic medication in inpatient pharmacotherapyArce, B. P. / Muro-perea, N. / Blanca-tamayo, M. / Perez-navarro, M. c. / Garcia-sanchez, L. / Sicras-maynar, A. et al. | 2009
- S352
-
P.1.i.0311 Predictors of treatment outcome with long-acting methylphenidate in attention deficit hyperactivity disorder in adultsRamos-Quiroga, J. A. / Kooij, S. / Trott, G. E. / Medori, J. R. / Dejonckheere, J. / van Oene, J. C. / Schauble, B. / Casas, M. / Buitelaar, J. et al. | 2009
- S353
-
P.1.i.034 Efficacy outcomes during longterm prolonged-release methylphenidate treatment of adults with ADHDImhof, L. / Nyerod, H. J. / Filipe, H. J. / Dejonckheere, J. / Wachter, S. / Schauble, B. / Buitelaar, J. / Kooij, S. / Casas, M. / Van Oene, J. C. et al. | 2009
- S354
-
P.1.i.035 Objective and subjective efficacy of ramelteon 4mg in adults with chronic insomniaHajak, G. / Ferini-Strambi, L. / Wang-Weigand, S. / Waldron, E. / Roth, T. et al. | 2009
- S355
-
P.1.i.037 Rater training on SANS and monitoring of rater performance during clinical trialsRicha, G. / DeSanti, S. / Schoemaker, J. et al. | 2009
- S356
-
P.1.i.039 Differences in melatonin therapy response in elderly patients with various ages at the onset of insomniaNastase, S. / Nastase, L. et al. | 2009
- S357
-
P.1.i.041 Sport, physical health and lyfestyle in psychiatric illnessFerrannini, L. / Venturino, C. / Pitto, C. / Ferrari, M. / Greco, P. et al. | 2009
- S358
-
P.1.i.043 Protective personality factors associated with premenstrual symptomatology in healthy womenGonda, X. / Telek, T. / Pap, D. / Csukly, G. / Fountoulakis, K. N. / Kiss, H. G. / Bagdjr, G. et al. | 2009
- S359
-
P.1.i.045 Lesion and stimulation of the mesolimbic motivational dopamine system influence peripheral blood lymphocyte numberPlucinska, K. / Grembecka, B. / Glac, W. / Badtke, P. / Jerzemowska, G. / Myslinska, D. / Wrona, D. et al. | 2009
- S361
-
P.2.a.002 An audit on informed choice in the treatment of depressionLuft, B. et al. | 2009
- S362
-
P.2.a.004 A comparative study on alexithymia in depressive, somatoform, anxiety, and psychotic disorders among KoreansLee, S. J. / Rim, H. D. / Jo, H. / Jeong, S. H. / Lee, Y. H. / Chung, U. S. / Lee, J. J. / Woo, J. M. / Park, Y. W. et al. | 2009
- S364
-
P.2.a.007 Screening for depression during pregnancyBunevicius, A. / Kusminskas, L. / Pop, V. J. / Pedersen, C. / Bunevicius, R. et al. | 2009
- S365
-
P.2.a.009 Prediction of response to serotonin reuptake inhibitors in patients with depression: QEEG cordance value as a predictorBares, M. / Brunovsky, M. / Novak, T. / Kopecek, M. / Stopkova, P. / Sos, P. / Krajca, V. et al. | 2009
- S366
-
R2.a.01l Risk factors of treatment resistance in major depression: results of multicenter TRES-DEP studyDudek, D. / Rybakowski, J. K. / Siwek, M. / Pawlowski, T. / Lojko, D. / Kiejna, A. et al. | 2009
- S368
-
P.2.a.014 The triallelic 5-HTTLPR polymorphism may be associated with major depression in male Han Chinese populationHuang, S. Y. / Shy, M. J. et al. | 2009
- S369
-
P.2.a.016 Increased neural responses to sad facial expressions in current but not remitted major depressionAmone, D. / Pegg, E. J. / McKie, S. / Downey, D. / Elliott, R. / Williams, S. R. / Anderson, I. M. et al. | 2009
- S370
-
P.2.a.018 Persistence and compliance to antidepressant treatment in patients with depression: a chart reviewSawada, N. / Uchida, H. / Suzuki, T. / Watanabe, K. / Kikuchi, T. / Nio, S. / Tsuboi, T. / Handa, T. / Kashima, H. et al. | 2009
- S371
-
P.2.a.020 The catechol-O-methyltransferase gene might be associated with males major depressionHuang, S. Y. / Shih, M. J. / Lin, C. L. / Lin, W. C. et al. | 2009
- S372
-
P.2.a.021 Insomnia as a predictor of depression in UK primary carede Vries, F. / Gallagher, A. M. / Lader, M. H. / Tylee, A. T. / Donoghue, J. / Cockle, S. M. / van Staa, T. P. / Nutt, D. J. et al. | 2009
- S373
-
P.2.a.023 Gender differences in symptoms and comorbidity patterns in Dutch depressive outpatients: the Leiden Routine Outcome Monitoring (ROM) Studyvan der Wee, N. / van Noorden, M. S. / Giltay, E. / den Hollander-Gijsman, M. / van der Lem, R. / Rood, Y. / Zitman, E. G. et al. | 2009
- S374
-
P.2.a.025 Neural effects of 7-day anti-depressant treatment on rewardMcCabe, C. / Cowen, P. J. / Harmer, C. J. et al. | 2009
- S375
-
P.2.a.027 Effect of bupropion for nicotine dependece in patients with major depressive disorder: an open clinical trialKim, H. / Lee, K. J. et al. | 2009
- S376
-
P.2.a.029 Comparison of treatment adherence between antidepressants monotherapy and antipsychotics augmentation with depressionJae, Y. M. / Jang, S. H. et al. | 2009
- S377
-
P.2.a.030 Decreased BDNF mRNA in blood peripheral mononuclear cells of patients with unipolar major depression, who had a lack effect on plasma BDNFLee, B. H. / Yoon, H. K. / Kim, Y. K. et al. | 2009
- S378
-
P.2.a.032 Resource use in depressed patients with sleep disturbanceGallagher, A. M. / De Vries, F. / Nutt, D. J. / Donoghue, J. / Tylee, A. T. / Cockle, S. M. / van Staa, T. P. / Lader, M. H. et al. | 2009
- S379
-
P.2.a.034 The risk of suicide and suicidal ideation in depressed patients with sleep disturbanceGallagher, A. M. / De Vries, F. / Tylee, A. T. / Lader, M. H. / Donoghue, J. / Cockle, S. M. / van Staa, T. P. / Nutt, D. J. et al. | 2009
- S380
-
P.2.a.035 Persistence with hypnotics in depressed patients treated in UK primary careGallagher, A. M. / De Vries, F. / Donoghue, J. / Nutt, D. J. / Tylee, A. T. / Cockle, S. M. / van Staa, T. P. / Lader, M. H. et al. | 2009
- S381
-
P.2.a.037 The efficacy and safety of milnacipran 50 mg bid in patients with major depression: the results of a clinical trialGogus, A. / Oral, T. / Berksun, O. / Karamustafalioglu, O. / Vahip, S. / Tunca, Z. / Yazici, O. et al. | 2009
- S382
-
P.2.a.039 Comparison of two different intensities of repetitive transcranial magnetic stimulation in drug resistant depressionKaramustafalioglu, O. / Uzun, U. E. / Tankaya, O. / Alpak, G. et al. | 2009
- S384
-
P.2.a.042 Comparison of six antidepressants in terms of time to discontinuationKarabulut, V. / Cengiz, Y. C. / Ozcelik, B. / Onem, R. / Tekin, A. / Tankaya, O. / Alpak, G. / Karamustafalioglu, O. et al. | 2009
- S385
-
P.2.a.044 Efficacy of trazodone in primary insomnia; a double-blind randomised placebo controlled polysomnographic studyPaterson, L. M. / Nutt, D. J. / Durant, C. / Wilson, S. J. et al. | 2009
- S387
-
P.2.a.047 A comparison of rating quality between subtitled and spoken Hamilton depression rating scale interviewsFriedmann, B. / Braxton, E. / Riordan, H. / Weber, C. J. / Murphy, M. F. / Cutler, N. R. et al. | 2009
- S388
-
P.2.a.049 Functional outcome after 12 months of deep brain stimulation for treatment resistant major depressive disorderRizvi, S. J. / Kennedy, S. H. / McNeely, H. / Giacobbe, P. / Mayberg, H. S. / Lozano, A. M. et al. | 2009
- S389
-
P.2.a.051 A systematic review and meta-analysis of sertraline for the treatment of depression in older peopleByrne, A. / Curran, S. et al. | 2009
- S390
-
P.2.a.052 Use of antidepressants in the treatment of major depressive disorder in an outpatient mental health centerGamier, C. / Diaz, B. / Alvaro, P. / Sanchis, R. / Castano, J. / Coreoles, D. / Martin, L. M. / Bulbena, A. et al. | 2009
- S391
-
P.2.b.002 Chronic stress changes expression of the axonal membrane glycoprotein M6a in the brainFlugge, G. / Cooper, B. / Alfonso, J. / Fuchs, E. et al. | 2009
- S392
-
P.2.b.004 Common structural features of the serotonin transporter identified by protein homology mappingKaschka, W. et al. | 2009
- S393
-
P.2.b.005 Magnetisation imaging in major depressive disordervan der Wee, N. / Boersma, C. / van Buchem, M. / Milles, J. / van Tol, M. J. / Aleman, A. / Demanescu, R. / Veltman, D. / Zitman, F. et al. | 2009
- S394
-
P.2.b.007 Pain and depression: occurrence of pain among patients with mild and moderate depressionKrysta, K. / Pasternak, K. / Prucnal, P. / Krupka-Matuszczyk, I. I. et al. | 2009
- S395
-
P.2.b.008 Metabotropic glutamate receptor 5: role in depression?Deschwanden, A. / Ametamey, S. M. / Johayem, A. / Westera, G. / Auberson, Y. / Buck, A. / Hasler, G. et al. | 2009
- S396
-
P.2.b.010 Evaluating nociceptive behaviour in the Wistar Kyoto rat model of depressionCalpin, P. / Burke, N. / Finn, D. P. / Roche, M. et al. | 2009
- S397
-
P.2.b.012 Long-term neurobiological changes by chronic mild stress and residual alterations after antidepressant discontinuationElizalde, N. / Garcia-Garcia, A. L. / Totterdell, S. / Gendive, N. / Venzala, E. / Ramirez, M. J. / Del Rio, J. / Tordera, R. M. et al. | 2009
- S399
-
P.2.b.015 Whole brain resting-state analysis reveals decreased connectivity in major depressive disorderVeer, I. / van der Wee, N. / Beckmann, C. / Baerends, E. / van Tol, M. / Ferrarini, L. / Milles, J. / Aleman, A. / Veltman, D. / Rombouts, S. et al. | 2009
- S400
-
P.2.b.017 Differences in 5-HT1A neurotransmission between rats displaying a persistent high or low exploratory phenotypeKoiv, K. / Harro, J. et al. | 2009
- S401
-
P.2.b.018 Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotypeAso, E. / Ozaita, A. / Busquets, A. / Serra, M. A. / Maldonado, R. et al. | 2009
- S402
-
P.2.b.020 5-HT2C receptor activation inhibits stress-induced increase in 5-HT transmission: relevance of receptor desensitization to the anxiolytic effect chronic antidepressant drugs and mutation in miceMongeau, R. / Martin, C. / Chevarin, C. / Maldonado, R. / Hamon, M. / Robledo, P. / Lanfumey, L. et al. | 2009
- S403
-
P.2.c.001 Paroxetine for the treatment of old age depression: a systematic reviewCurran, S. / Rampat, R. / Spencer, R. / Minogue, V. / Wattis, J. et al. | 2009
- S404
-
P.2.c.003 Mecamylamine improved disability of depressed subjects who did not respond adequately to citalopramHosford, D. / Kuchibhatla, R. / Dunbar, G. et al. | 2009
- S405
-
P.2.c.004 Basic fibroblast growth factor (FGF2) gene polymorphisms could contribute to SSRIs treatment response and tolerabilityKato, M. / Okugawa, G. / Wakeno, M. / Takekita, Y. / Nounen, S. / Tetsuo, S. / Azuma, J. / Serretti, A. / Kinoshita, T. et al. | 2009
- S406
-
P.2.c.006 Analysis of longitudinal clinical scores in major depressive disorder trials: comparison of linear and non-linear mixed effect modellingIavarone, L. / Gomeni, R. et al. | 2009
- S407
-
P.2.c.008 Serotonin transporter gene polymorphisms, personality and response to serotonergic and noradrenergic antidepressantsTranter, R. / Muthuvelu, P. / Bell, D. / Juhasz, G. / Anderson, I. M. et al. | 2009
- S408
-
P.2.c.009 Duloxetine versus iv citalopram in partial/non responder depressed patients: a randomized placebo-controlled studyDellOsso, B. / Buoli, M. / Albano, A. / Bortolussi, S. / Benatti, B. / Balossi, I. / Oldani, L. / Altamura, A. C. et al. | 2009
- S409
-
P.2.c.011 Duloxetine modulates pain-related brain response in patients with major depressive disorderCardoner, N. / Lopez-Sola, M. / Pujol, J. / Hernandez-Ribas, R. / Deus, J. / Ortiz, H. / Harrison, B. J. / Soriano-Mas, C. / Martinez_Amoros, E. / Menchon, J. M. et al. | 2009
- S411
-
P.2.c.014 Duloxetine in the treatment of depression comorbid with anxiety: a pilot study with 12-month outcomesBassetti, R. / Bosi, M. F. / Colombo, A. / Roaro, A. / Truzoli, R. / Ba, G. et al. | 2009
- S412
-
P.2.c.016 Superior efficacy results of agomelatine versus main current SSRI/SNRI antidepressants in a pooled-analysisKasper, S. / Hale, A. / Lemoine, P. et al. | 2009
- S413
-
P.2.c.017 Patients behaviours towards side effects of antidepressants with a focus on gender-differenceKikuchi, T. / Uchida, H. / Suzuki, T. / Kitahata, R. / Hirano, J. / Tomita, M. / Watanabe, K. / Kashima, H. et al. | 2009
- S414
-
P.2.c.019 Lamotrigine use for unipolar depression in KoreaSim, H. / Kang, E. / Lee, D. et al. | 2009
- S415
-
P.2.c.021 Efficacy and safety of combined therapy with moclobemide and valproic acid or carbamazepine in depressive patientsTodorovic, M. / Ignjatovic, A. R. / Miljkovic, B. / Todorovic, D. / Timotijevic, I. et al. | 2009
- S416
-
P.2.c.023 Discerning the etiology of sexual dysfunction in Turkish patients with major depressive disorder: a preliminary studyTufan, A. / Ozten, E. / Isik, S. et al. | 2009
- S417
-
P.2.c.024 024 Association study between BDNF genetic polymorphism and treatment responses of SSRI in major depressive disorderLee, Y. / Jung, Y. / Park, J. / Kim, S. / Kim, J. / Kang, C. / Lee, B. / Lee, D. et al. | 2009
- S418
-
P.2.c.026 Superior antidepressant efficacy of agomelatine vs fluoxetine in severe major depressive disorder patients: a randomised, double-blind studyHale, A. / Corral, R. / Mencacci, O. / Ruiz, J. S. / Severo, C. A. / Gentil, V. et al. | 2009
- S419
-
P.2.c.028 Agomelatine antidepressant: advantages over sertraline and venlafaxine in clinical effectivenessKennedy, S. H. et al. | 2009
- S420
-
P.2.c.029 Suicide risk and choice of antidepressantAgius, M. / Zaman, R. / Gilhooley, M. / Davis, A. et al. | 2009
- S421
-
P.2.c.031 Safety and tolerability of adjunctive aripiprazole in major depressive disorder: pooled data from 3 short-term studiesLoze, J. Y. / Gismondi, R. / McQuade, R. / Carson, W. / Berman, R. et al. | 2009
- S422
-
P.2.c.033 Psychotropic medication in Spanish population setting: treatment adequacy for major depressive disorderBlanca-Tamayo, M. / Sicras-Mainar, A. / Pascual-Arce, B. / Perez-Navarro, M. C. / Navarro-Artieda, R. / Garcia-Sanchez, L. / Muro-Perea, N. et al. | 2009
- S423
-
P.2.c.034 Prefrontal metabolic abnormalities in major depressive disorder: a proton magnetic resonance spectroscopy studyPortella, M. J. / Morgan-Ferrando, R. / Gomez-Anson, B. / De Diego-Adelino, J. / Puigdemont, D. / Perez-Egea, R. / Alvarez, E. / Ruscalleda, J. / Perez, V. et al. | 2009
- S424
-
P.2.c.036 Increase of 5-HTT occupancy during escitalopram or citalopram treatment correlates with antidepressant efficacy in major depressive disorderAkimova, E. / Savli, M. / Haeusler, D. / Fink, M. / Hahn, A. / Wadsak, W. / Mitterhauser, M. / Lanzenberger, R. / Kletter, K. / Kasper, S. et al. | 2009
- S425
-
P.2.c.038 Duloxetine versus placebo in patients with major depressive disorder (MDD): assessment of energy and vitality in MDDMyers-Oakes, T. M. / Thase, M. E. / Meyers, A. L. / Ahl, J. / Prakash, A. / Marangell, L. B. et al. | 2009
- S426
-
P.2.c.040 A randomised, double-blind, placebo-controlled, active-referenced study of Lu AA21004 in patients with major depressionArtigas, F. / Dragheim, M. / Loft, H. / Perez, V. / Alvarez, E. et al. | 2009
- S427
-
P.2.c.042 Effects of escitalopram on the modulation of the identification of facial expressions by healthy women: a fMRI studyDel-Ben, C. M. / Sponholz, A. / Shuhama, R. / McKie, S. / Deakin, J. F. / Graeff, F. G. et al. | 2009
- S428
-
P.2.c.044 Developing guidelines for the treatment of resistant unipolar depression across primary and secondary careAgius, M. / Zaman, R. / Klepacka, K. et al. | 2009
- S430
-
P.2.d.002 The phosphodiesterase 2 inhibitor BTT5001 demonstrates anxiolytic, anti-depressive and pro-cognitive efficacy in vivoLangen, B. / Hage, T. / Stange, H. et al. | 2009
- S432
-
P.2.d.005 Effects of chronic treatment with 7-nitroindazole on rat hippocampal gene and protein expression after swimming stressFerreira, F. / Joca, S. / Pinheiro, D. / Santos, A. / Silva, W. / Catalan, A. / Greene, L. / Guimaraes, F. et al. | 2009
- S433
-
P.2.d.007 Reversible inactivation of the medial prefrontal cortex induces antidepressant-like effects in ratsGuimaraes, F. S. / Scopinho, A. A. / Scopinho, M. A. / Correa, F. M. / Joca, S. R. et al. | 2009
- S434
-
P.2.d.009 Differential effects of fluoxetine or venlafaxine treatment on maternal separation, an experimental model of depressionMartisova, E. / Aisa, B. / Tordera, R. / Lasheras, B. / Del Rio, J. / Ramirez, M. J. et al. | 2009
- S435
-
P.2.d.010 Single and chronic agomelatine treatment differently affect cerebral a1-adrenergic receptorsNalepa, I. / Wieczerzak, K. / Kowalska, M. / Nawrat, D. / Vetulani, J. et al. | 2009
- S436
-
P.2.d.012 Ketamine, memantine and traxoprodil for treatment of depression: in vivo neurochemical mechanism of actionSmagin, G. N. / Song, D. / Wang, H. / Doherty, J. J. / Palamarchouk, V. S. et al. | 2009
- S437
-
P.2.d.014 Evaluation of the antidepressant effect of new synthesized alpha2-adrenoceptor antagonistsMuguruza, C. / Rodriguez, F. / Ortega, J. E. / Urigiien, L. / Meana, J. J. / Rozas, I. / Callado, L. F. et al. | 2009
- S438
-
P.2.d.016 The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changesTamburella, A. / Micale, V. / Leggio, G. M. / Drago, F. et al. | 2009
- S439
-
P.2.d.018 Mechanisms contributing to the regulation of the different phases of neurogenesis by agomelatineSoumier, A. / Lortet, S. / Masmejean, F. / Gabriel, C. / Mocaer, E. / Millan, M. / Daszuta, A. et al. | 2009
- S440
-
P.2.d.019 Effects of chronic agomelatine administration on the expression of a panel of genes in various brain areas of ratsVarcoe, T. J. / Salkeld, M. / Mocaer, E. / Seguin, L. / Kennaway, D. J. et al. | 2009
- S441
-
P.2.d.021 Agomelatine reduces glutamate release induced by acute stress, possible synergism between melatonin and 5HT2C propertiesMallei, M. / Zappettini, S. / Musazzi, L. / Mocaer, E. / Gabriel, C. / Milanese, M. / Bonanno, G. / Popoli, M. et al. | 2009
- S442
-
P.2.d.023 Synergic mechanisms in the modulation of BDNF and Arc following agomelatine administrationCalabrese, F. / Molteni, R. / Pisoni, S. / Gabriel, C. / Mocaer, E. / Racagni, G. / Riva, M. A. et al. | 2009
- S443
-
P.2.d.025 Paroxetine treatment in women with menopausal depressionFilovska, V. F. / Jakovcevska, M. J. / Dimova, O. D. / Nedzipi, I. N. et al. | 2009
- S444
-
P.2.d.027 Psychopharmacological therapy of depressed patients requiring in-patient careDavid, E. / Balint, M. / Frey, E. / Papp, R. / Gazdag, G. et al. | 2009
- S445
-
P.2.d.029 The influence of mianserin on cytokines plasma levels in rats under chronic mild stressManikowska, K. / Mikolajczak, P. / Wojtys, M. / Bobkiewicz-Kozlowska, T. et al. | 2009
- S447
-
P.2.d.032 Glycogen synthase kinase 3 (GSK-3b) an emerging target for neurological disease: in silico study to investigate the binding mode of trazodoneOmbrato, R. / Alisi, M. A. / Cazzolla, N. / Corso, G. / Manelfi, C. / Mangano, G. / Magnani, M. / Milanese, C. / Olivieri, L. / Polenzani, L. et al. | 2009
- S448
-
P.2.e.00l Predominant polarity as an outcome predictor in a clinical trial for bipolar depressionPacchiarotti, I. P. / Rosa, A. R. / Mazzarini, L. M. / Colom, F. / Tohen, M. / Vieta, E. et al. | 2009
- S449
-
P.2.e.003 Mixed symptoms of bipolar disorder related to nicotine dependence but not current smoking in young menYeh, C. B. / Gau, S. S. / Mao, W. C. / Shyu, J. F. et al. | 2009
- S450
-
P.2.e.004 Age at onset in bipolar disorderPaik, I. H. / Ham, W. / Woo, Y. S. / Park, M. H. et al. | 2009
- S451
-
P.2.e.006 Prophylactic effect of lithium in maintenance treatment of bipolar disorder is associated with plasma levels >0.6 mEq/LNolen, W. A. / Paulsson, B. / Weisler, R. H. et al. | 2009
- S452
-
P.2.e.008 Cardiovascular and respiratory comorbidities in patients with bipolar disorder: a systematic reviewMontes, J. M. / Saiz-Ruiz, J. / Vieta, E. / Mostaza, J. / Rico-Villademoros, F. / Bobes, J. et al. | 2009
- S453
-
P.2.e.009 Gynaecological and obstetric comorbidities in patients with bipolar disorder: a systematic reviewBobes, J. / Montes, J. M. / Mostaza, J. / Rico-Villademoros, F. / Vieta, E. / Saiz-Ruiz, J. et al. | 2009
- S454
-
P.2.e.01l Characteristics of patients with bipolar disorder presenting a current major depressive episode: analysis in 8 countriesYoung, A. H. / Angst, J. / Azorin, J. M. / Bowden, C. L. / Perugi, G. / Vieta, E. et al. | 2009
- S455
-
P.2.e.013 Seasonal variations in bipolar disorder admissions in GalizaRamos, I. V. / De Usabel, P. / Mota, M. J. / Arauxo, A. et al. | 2009
- S457
-
P.2.e.016 Sensitivity of a comprehensive rating scale for bipolar disorders to assess improvements with treatmentBowden, C. / Mintz, J. / Gonzalez, J. / Singh, V. / Thompson, P. / Bernardo, C. et al. | 2009
- S458
-
P.2.e.018 Thyroid function index and recurrence in patients with bipolar disordersKang, J. M. / Han, D. H. / Joo, S. Y. / Kim, J. W. et al. | 2009
- S459
-
P.2.e.020 Effects of pharmacological treatment on the use of episodic memory storage and recall strategies in bipolar I disorderLopez-Jaramillo, C. / Lopera-Vasquez, J. P. / Gallo, A. / Ospina-Duque, J. et al. | 2009
- S461
-
P.2.e.023 Axis I psychiatric comorbidity in Korean patients with bipolar disorder: prevalence and response to treatmentCha, B. / Moon, E. S. / Jeong, C. Y. / Ha, K. et al. | 2009
- S462
-
P.2.e.025 Ziprasidone with adjunctive mood stabilizer in maintenance treatment of bipolar disorder: metabolic profilesKarayal, O. / Ice, K. / Chappell, P. / Schwartz, J. / Siu, C. / Pappadopulos, E. et al. | 2009
- S463
-
P.2.e.027 Do mood stabilizers protect patients with bipolar disorders from negative effects of life events?Ben Nasr, S. / El Kissy, Y. / Amara, G. H. / Hamdi, R. / Ben Hadj Ali, B. et al. | 2009
- S464
-
P.2.e.028 Prevalence and correlates of obesity and overweight during treatment in patients with bipolar I disorderMechri, A. / Ezzaher, A. / Haj Mouhamed, D. / DouM, W. / Najjar, M. E. / Gaha, L. et al. | 2009
- S465
-
P.2.e.030 Creatine kinase level may not be associated with motor activity but with simple mood state in Korean unmedicated bipolar patientsChung, S. / Choi, M. S. / Ha, T. S. / Yang, J. C. / Park, T. W. / Chung, Y. C. / Jung, A. J. et al. | 2009
- S466
-
P.2.e.032 Patterns in European and rest of world use of doctorate level raters in bipolar and schizophrenia clinical trialsDaniel, D. / Bartko, J. / Sartorius, N. / Vieta, E. / Butler, A. / Moya, G. et al. | 2009
- S468
-
P.2.e.035 Is bipolar affective disorder under-diagnosed in secondary care in the UK?Agius, M. / Iankov, B. / Murphy, L. / Zaman, R. et al. | 2009
- S469
-
P.2.e.037 The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trialKnesevich, M. / Papadakis, K. / Bose, A. / Andor, G. / Laszlovszky, I. et al. | 2009
- S470
-
P.2.e.039 Prevalence and correlates of non-adherence with mood stabilisers in patients with bipolar I disorderMechri, A. / Bouzgarrou, L. / Mrad, A. / DouM, W. / Najjar, M. F. / Gaha, L. et al. | 2009
- S471
-
P.2.g.001 Correlation between smoking and depressionGrecu, I. G. / Grecu, M. G. / Moica, T. / Vesa, A. / Crisan, R. / Florea, M. / Buicu, G. / Grecu, C. G. et al. | 2009
- S472
-
P.2.g.002 Mean platelet volume in patients with major depression: effect of escitalopram treatmentCanan, F. / Ataoglu, A. et al. | 2009
- S473
-
P.2.g.004 Effect of escitalopram treatment on white blood cells in patients with major depressionCanan, F. / Ataoglu, A. / Ozcetin, A. et al. | 2009
- S474
-
P.2.g.006 Effects of phosphatidylserine on depression in the elderlyKomori, T. / Matsumoto, T. / Motomura, E. / Shiroyama, T. et al. | 2009
- S475
-
P.2.g.008 Effects of lemon and valerian inhalation on autonomic nerve activity in depressed and healthy subjectsKomori, T. / Matsumoto, T. / Motomura, E. / Shiroyama, T. et al. | 2009
- S476
-
P.2.g.010 Dissociative symptoms in patients with mood and anxiety disorders and potential correlation to antidepressant responseMoscariello, M. M. / Ratti, F. / Quartini, A. / Forcen, F. E. / Munuera, J. N. / Bersani, G. et al. | 2009
- S479
-
P.2.h.003 Comparison of the stress factors impact on HPA in patients with depression and neurosis - study with the use of the Dexamethasone Supression TestSpila, B. / Dubas-Slemp, H. / Urbanska, A. / Bartczuk, R. / Grzywa-Celinska, A. et al. | 2009
- S480
-
P.3.a.001 Sequential IM/oral ziprasidone and haloperidol in agitated patients with Schizophrenia: A naturalistic comparisonFernando, C. / Perez-Sola, V. / Gutierrez-Fraile, M. / Gutierrez-Casares, J. R. / Mesa, F. et al. | 2009
- S481
-
P.3.a.003 The revolving door patients - are they different?Grubic, V. N. / Zalar, B. / Saje, M. et al. | 2009
- S482
-
P.3.a.005 Expert rater assisted score evaluation: a new method to increase efficiency in drug development programsSchoemaker, J. / Gaur, R. / Chawla, V. / Szegedi, A. et al. | 2009
- S483
-
P.3.a.006 Psychological treatment in the first psychotic episodePerez, P. V. / De Azua, S. R. / Martinez, M. / Ron, S. / Oliveros, R. G. / Asua, J. / Gonzalez-Pinto, A. et al. | 2009
- S484
-
P.3.a.008 Effects of cognitive remediation in schizophrenia patientsRodriguez, M. / Kawaciukova, R. / Bankovska-Motlova, L. / Mohr, P. / Dragomirecka, E. V. / Novak, T. / Preiss, M. / Sediva, J. et al. | 2009
- S485
-
P.3.a.010 Clinical outcome in first episode of schizophreniaMacrea, R. / Miclutia, I. / Popescu, C. A. et al. | 2009
- S486
-
P.3.a.012 A study of the clinical outcome following treatment discontinuation after remission in first-episode schizophreniaEmsley, R. / Oosthuizen, P. / Koen, L. / Niehaus, D. / Martinez, L. et al. | 2009
- S487
-
P.3.a.013 Insight and clinical outcome in first episode psychosis: 1-year follow-up studyMorelli, C. / Ayesa-Arriola, R. / Pelayo-Teran, J. M. / Rodriguez-Sanchez, J. M. / Perez-Iglesias, R. / Mata, I. / Crespo-Facorro, B. et al. | 2009